BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14:535-545. [PMID: 32408118 DOI: 10.1016/j.dsx.2020.04.044] [Cited by in Crossref: 325] [Cited by in F6Publishing: 349] [Article Influence: 108.3] [Reference Citation Analysis]
Number Citing Articles
1 Brown SA, Becker HA, García AA, Velasquez MM, Tanaka H, Winter MA, Perkison WB, Brown EL, Aguilar D, Hanis CL. Acculturation, Dietary Behaviors, and Macronutrient Intake Among Mexican Americans With Prediabetes: The Starr County Diabetes Prevention Initiative. Sci Diabetes Self Manag Care 2023;:26350106221146473. [PMID: 36683588 DOI: 10.1177/26350106221146473] [Reference Citation Analysis]
2 Meregildo-rodriguez ED, León-jiménez FE, Tafur-hoyos BAD, Vásquez-tirado GA. Impact of the COVID-19 pandemic on the incidence and clinical outcomes of diabetic ketoacidosis among male and female children with type 1 diabetes: systematic review and meta-analysis. F1000Res 2023;12:72. [DOI: 10.12688/f1000research.128687.1] [Reference Citation Analysis]
3 Indrambarya T, Chaichalothorn M, Sirinawin C, Namchaisiri J, Susantitaphong P. Mortality rate in patients with SAR-COV-2 infection treated with extracorporeal membrane oxygenator: A systematic review and meta-analysis. Heart Lung 2023;58:204-9. [PMID: 36621103 DOI: 10.1016/j.hrtlng.2022.12.012] [Reference Citation Analysis]
4 Pettersson S, Jaarsma T, Hedgärd K, Klompstra L. Self-care in migrants with type 2 diabetes, during the COVID-19 pandemic. J Nurs Scholarsh 2023;55:167-77. [PMID: 36353793 DOI: 10.1111/jnu.12842] [Reference Citation Analysis]
5 Sharifi F, Mehrolhassani MH, Ahmadi Gohari M, Karamoozian A, Jahani Y. Clinical Risk Factors of Need for Intensive Care Unit Admission of COVID-19 Patients; a Cross-sectional Study. Arch Acad Emerg Med 2023;11:e15. [PMID: 36620731 DOI: 10.22037/aaem.v11i1.] [Reference Citation Analysis]
6 Jain S, Dhall M. Social Isolation in COVID-19: Impact of Loneliness and NCDs on Mental and Physical Health of Older Adults. Handbook of Aging, Health and Public Policy 2023. [DOI: 10.1007/978-981-16-1914-4_187-1] [Reference Citation Analysis]
7 Williams V, Onwuchekwa C, Vos AG, Grobbee DE, Otwombe K, Klipstein-Grobusch K. Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021. Glob Health Action 2022;15:2114146. [PMID: 36178364 DOI: 10.1080/16549716.2022.2114146] [Reference Citation Analysis]
8 Abilbayeva A, Tarabayeva A, Idrisova G, Abdrakhmanova A, Sadykova A, Yegemberdiyeva R, Duisenova A. Clinical and laboratory COVID-19 features in hospitalized patients with concomitant diabetes mellitus type 2: A retrospective study. J CLIN MED KAZ 2022;19:83-88. [DOI: 10.23950/jcmk/12719] [Reference Citation Analysis]
9 Nishino K, Nakagawa K, Yase E, Terashima M, Murata T. Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes. Diabetol Int 2022;:1-5. [PMID: 36575722 DOI: 10.1007/s13340-022-00614-w] [Reference Citation Analysis]
10 Zhang L, Jiang L, Tian T, Li W, Pan Y, Wang Y. Efficacy and Safety of COVID-19 Vaccination in Older Adults: A Systematic Review and Meta-Analysis. Vaccines (Basel) 2022;11. [PMID: 36679878 DOI: 10.3390/vaccines11010033] [Reference Citation Analysis]
11 van den Berg JM, Remmelzwaal S, Blom MT, van Hoek BACE, Swart KMA, Overbeek JA, Burchell GL, Herings RMC, Elders PJM. Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review. Vaccines (Basel) 2022;11:24. [PMID: 36679869 DOI: 10.3390/vaccines11010024] [Reference Citation Analysis]
12 Catalano A, Dansero L, Gilcrease GW, Macciotta A, Saugo C, Manfredi L, Gnavi R, Strippoli E, Zengarini N, Caramello V, Costa G, Sacerdote C, Ricceri F. Multimorbidity and SARS-CoV-2 related outcomes: analysis on an Italian sample of 12.793 infected patients. JMIR Public Health Surveill 2022. [PMID: 36626821 DOI: 10.2196/41404] [Reference Citation Analysis]
13 Shams Aldeen M, Logman Masaad M, Azhary A, Suliman A, Alziber MA, MohammedAhmed M, Mohamed Aman FA, Ismail S, Abuzeid N, Musa AO, Mengistu ST, Hamida ME. The Presence of Antineutrophil Cytoplasmic Antibodies and Antiphospholipid Antibodies in Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A Case-Control Study among Sudanese Patients. Interdiscip Perspect Infect Dis 2022;2022:6511198. [PMID: 36570594 DOI: 10.1155/2022/6511198] [Reference Citation Analysis]
14 Doppen M, Mirjalili A, Harwood M, Eathorne A, Braithwaite I, Bong J, Kirton L, Semprini R, Weatherall M, Semprini A, Kearns C, Black M, Kung S, Walton M, Beasley R, Hills T. COVID-19 vaccination and the skin to deltoid MUSCLE distance in adults with diabetes. Vaccine X 2023;13:100248. [PMID: 36536872 DOI: 10.1016/j.jvacx.2022.100248] [Reference Citation Analysis]
15 Dahlia D, Artanti KD, Hargono A, Martini S, Nasr NMG, Li C. Death risk among COVID-19 patients with diabetes mellitus. J Public Health Afr 2022;13. [DOI: 10.4081/jphia.2022.2399] [Reference Citation Analysis]
16 AlAhmari F, Preethanath RS, Divakar DD, Ali D. Association of Peri-Implant Health Status With COVID-19. Int Dent J 2022:S0020-6539(22)00275-1. [PMID: 36642571 DOI: 10.1016/j.identj.2022.11.019] [Reference Citation Analysis]
17 Alkhemeiri A, Al Zaabi S, Lakshmanan J, El-Khatib Z, Awofeso N. COVID-19 Case Management Outcomes Amongst Diabetes and Hypertensive Patients in the United Arab Emirates: A Prospective Study. Int J Environ Res Public Health 2022;19. [PMID: 36498037 DOI: 10.3390/ijerph192315967] [Reference Citation Analysis]
18 Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, Zhang S. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med 2022;20:444. [DOI: 10.1186/s12916-022-02656-y] [Reference Citation Analysis]
19 Temel HE, Altıntop MD, Sever B, Özdemir A, Akalın Çiftçi G. In vitro evaluation of 2-pyrazoline derivatives as DPP-4 inhibitors. Turkish Journal of Biochemistry 2022;0. [DOI: 10.1515/tjb-2022-0161] [Reference Citation Analysis]
20 Makovski TT, Ghattas J, Monnier Besnard S, Ambrozova M, Vasinova B, Feteira-santos R, Bezzegh P, Ponce Bollmann F, Cottam J, Haneef R, Devleesschauwer B, Speybroeck N, Nogueira P, Forjaz MJ, Coste J, Carcaillon-bentata L. Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic characteristics in the development of SARS-CoV-2 health outcomes: protocol for systematic reviews of population-based studies. BMJ Open 2022;12:e063573. [DOI: 10.1136/bmjopen-2022-063573] [Reference Citation Analysis]
21 Solnceva TD, Lachugin AA, Sivakova OA, Chazova IE. Features of the manifestation of arterial hypertension in patients with a new coronavirus infection. Evrazijskij kardiologičeskij žurnal 2022. [DOI: 10.38109/2225-1685-2022-3-90-96] [Reference Citation Analysis]
22 Keykavousi K, Nourbakhsh F, Abdollahpour N, Fazeli F, Sedaghat A, Soheili V, Sahebkar A, Alahmad W. A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease. International Journal of Analytical Chemistry 2022;2022:1-14. [DOI: 10.1155/2022/9006487] [Reference Citation Analysis]
23 Mannucci F, Vitturi G, Benacchio L, Sbrogiò LG, Bano F, Lapolla A, Piarulli F, Giron MC, Avogaro A, Fadini GP. Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study. Diabetes Metab Syndr Obes 2022;15:3093-101. [PMID: 36237966 DOI: 10.2147/DMSO.S385646] [Reference Citation Analysis]
24 Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N, Al Zumai O, Alrubayan F, Asiri A, Alkahtani N, Alolayan A, Alsohimi S, Melibari N, Almagthali A, Aljahdali S, Alenazi AA, Alsaeedi AS, Al Ghamdi G, Al Faris O, Alqahtani J, Al Qahtani J, Alshammari KA, Alshammari KI, Aljuhani O. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Crit Care 2022;26:304. [PMID: 36192801 DOI: 10.1186/s13054-022-04158-y] [Reference Citation Analysis]
25 Kabirpanthi V, Gupta V, Singh A. Clinical features and haematological parameters associated with COVID-19 severity among hospitalized patients: A retrospective observational study from Tribal Central India. J Family Med Prim Care 2022;11:6042-8. [PMID: 36618258 DOI: 10.4103/jfmpc.jfmpc_138_22] [Reference Citation Analysis]
26 Fukushima T, Chubachi S, Namkoong H, Asakura T, Tanaka H, Lee H, Azekawa S, Okada Y, Koike R, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID-19: Integrative analysis from the Japan COVID-19 task force. Diabetes Obes Metab 2023;25:144-55. [PMID: 36056760 DOI: 10.1111/dom.14857] [Reference Citation Analysis]
27 Kumar R, Kumar V, Arya R, Anand U, Priyadarshi RN. Association of COVID-19 with hepatic metabolic dysfunction. World J Virol 2022; 11(5): 237-251 [DOI: 10.5501/wjv.v11.i5.237] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Monod C, Kotzaeridi G, Eppel D, Linder T, Bozkurt L, Hösli I, Göbl CS, Tura A. Assessment of glucose levels in pregnant women with history of COVID-19 in a case-control study. Front Physiol 2022;13:988361. [DOI: 10.3389/fphys.2022.988361] [Reference Citation Analysis]
29 S. AK, Singh V, Singi Y, Ranjan R. The Association of Hematological and Biochemical Parameters With Mortality Among COVID-19 Patients: A Retrospective Study From North India. Cureus 2022. [DOI: 10.7759/cureus.29198] [Reference Citation Analysis]
30 Sarkar A, Sanyal S, Majumdar A, Tewari DN, Bhattacharjee U, Pal J, Chakrabarti AK, Dutta S. Development of lab score system for predicting COVID-19 patient severity: A retrospective analysis. PLoS ONE 2022;17:e0273006. [DOI: 10.1371/journal.pone.0273006] [Reference Citation Analysis]
31 Zulueta M, Aurrekoetxea J, Mendizabal L, Gaztambide S, Arregi M, Hoz AB, Arana-arri E, Saso L, Gomez-conde S, Martinez-salazar R, Urrutia I, Sanchez-moran M, Garcia-castaño A, Pérez-nanclares G, Velasco O, Calvo B, Simon L, Castaño L. Severe COVID-19 in the Basque Country, Spain: Risk Prediction Model with Genetic and Clinical Factors.. [DOI: 10.21203/rs.3.rs-2015865/v1] [Reference Citation Analysis]
32 Parthasarathy S, Chamorro-pareja N, Kharawala A, Hupart KH, Curcio J, Coyle C, Buchnea D, Karamanis D, Faillace R, Palaiodimos L, Kishore P. Diabetic Ketoacidosis Was Associated with High Morbidity and Mortality in Hospitalized Patients with COVID-19 in the NYC Public Health System. Diabetology 2022;3:477-493. [DOI: 10.3390/diabetology3030036] [Reference Citation Analysis]
33 Muzy J, Campos M, Emmerick I, Avelar FGD. Characterization of primary health care for patients with diabetes based on the PMAQ-AB. Ciênc saúde coletiva 2022;27:3583-602. [DOI: 10.1590/1413-81232022279.17542021en] [Reference Citation Analysis]
34 Muzy J, Campos M, Emmerick I, Avelar FG. Characterization of primary health care for patients with diabetes based on the PMAQ-AB. Cien Saude Colet 2022;27:3583-602. [PMID: 36000646 DOI: 10.1590/1413-81232022279.17542021] [Reference Citation Analysis]
35 Valtierra-Alvarado MA, Castañeda-Delgado JE, Lugo-Villarino G, Dueñas-Arteaga F, Rivas-Santiago B, Enciso-Moreno JA, Serrano CJ. Increased frequency of CD14+HLA-DR-/low cells in type 2 diabetes patients with poor glycemic control. Hum Immunol 2022:S0198-8859(22)00166-5. [PMID: 36028458 DOI: 10.1016/j.humimm.2022.08.011] [Reference Citation Analysis]
36 Lamba M, Mishra PR, Verma R, Bharti A, Punia V, Mittal S. The COVID-19 Clinical Spectrum and the Effect of Associated Comorbidities on Illness Severity in the North Indian Population: A Cross-Sectional Study. Cureus 2022. [DOI: 10.7759/cureus.28192] [Reference Citation Analysis]
37 Pelle MC, Zaffina I, Provenzano M, Moirano G, Arturi F. COVID-19 and diabetes—Two giants colliding: From pathophysiology to management. Front Endocrinol 2022;13:974540. [DOI: 10.3389/fendo.2022.974540] [Reference Citation Analysis]
38 Olesen K, Joensen LE, Madsen KP, Willaing I. How has the COVID-19 Pandemic Affected Diabetes Self-Management in People With Diabetes? - A One-Year Follow-Up Study. Front Clin Diabetes Healthc 2022;3. [DOI: 10.3389/fcdhc.2022.867025] [Reference Citation Analysis]
39 Menekli T, Yaprak B, Türeyen A, Şentürk S. Investigation of COVID-19 fear, treatment compliance, and metabolic control of patients with type 2 diabetes mellitus during the pandemic. Prim Care Diabetes 2022:S1751-9918(22)00134-6. [PMID: 36030171 DOI: 10.1016/j.pcd.2022.08.005] [Reference Citation Analysis]
40 de Carvalho FC, da Silva ET, de Almeida WAF, Maroneze MA, Schwartz JDA, Jardim JPV, Peixoto HM. Clinical and epidemiological aspects of severe acute respiratory infection: before and during the first year of the COVID-19 pandemic in Brazil. Transactions of The Royal Society of Tropical Medicine and Hygiene 2022. [DOI: 10.1093/trstmh/trac074] [Reference Citation Analysis]
41 Yanamandra U, Rajagopal S, Aggarwal B, Kaur P, Singh A, Aggarwal N, Sai Kumar PB, Duhan G, Sahu R, Menon A. Sweetness and positivity together aren't a happy ending: Case controlled study amongst severe COVID-19 for impact of diabetes mellitus on survival. Medical Journal Armed Forces India 2022. [DOI: 10.1016/j.mjafi.2022.06.010] [Reference Citation Analysis]
42 Amin MN, Bahoosh SR, Eftekhari M, Hosseinzadeh L. Herbal Sources of Magnesium as a Promising Multifaceted Intervention for the Management of COVID-19. Natural Product Communications 2022;17:1934578X2211162. [DOI: 10.1177/1934578x221116235] [Reference Citation Analysis]
43 Dimka J, van Doren TP, Battles HT. Pandemics, past and present: The role of biological anthropology in interdisciplinary pandemic studies. American Journal of Biological Anthropology 2022;178:256-291. [DOI: 10.1002/ajpa.24517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Skwiersky S, Rosengarten S, Meisel T, Macaluso F, Chang M, Thomson A, Da Silva B, Oommen A, Salvani J, Banerji MA. Sugar is not always sweet: exploring the relationship between hyperglycemia and COVID-19 in a predominantly African American population. BMJ Open Diabetes Res Care 2022;10:e002692. [PMID: 36002176 DOI: 10.1136/bmjdrc-2021-002692] [Reference Citation Analysis]
45 Gholinataj Jelodar M, Mirzaei S, Dehghan Chenari H. Impact of IFN‐β1a in treatment of a COVID‐19 patient with beta thalassemia and diabetes mellitus: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6114] [Reference Citation Analysis]
46 Rangel ÉB, de Lucena DD, Aguiar-brito I, de Andrade LGM, Veronese-araújo A, Cristelli MP, Tedesco-silva H, Medina-pestana JO. COVID-19 in Kidney Transplant Recipients With Diabetes Mellitus: A Propensity Score Matching Analysis. Transpl Int 2022;35:10375. [DOI: 10.3389/ti.2022.10375] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Bepouka B, Odio O, Mangala D, Mayasi N, Mandina M, Longokolo M, Makulo JR, Mbula M, Kayembe JM, Situakibanza H. Diabetes Mellitus is Associated With Higher COVID-19 Mortality Rates in Sub-Saharan Africa: A Systematic Review and Meta-analysis. Cureus 2022. [DOI: 10.7759/cureus.26877] [Reference Citation Analysis]
48 Huang XY, Yang LJ, Hu X, Zhang XX, Gu X, Du LJ, He ZY, Gu XJ. Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study. World J Diabetes 2022; 13(7): 543-552 [DOI: 10.4239/wjd.v13.i7.543] [Reference Citation Analysis]
49 Bajpeyi S, Mossayebi A, Kreit H, Cherukuri S, Mandania RA, Concha JB, Jung H, Wagler A, Gupte A, Deoker A. Unmanaged Diabetes and Elevated Blood Glucose Are Poor Prognostic Factors in the Severity and Recovery Time in Predominantly Hispanic Hospitalized COVID-19 Patients. Front Endocrinol 2022;13:861385. [DOI: 10.3389/fendo.2022.861385] [Reference Citation Analysis]
50 Austin AM, Leggett CG, Schmidt P, Bolin P, Nelson EC, Oliver BJ, King AC. Utilization Patterns and Outcomes of People With Diabetes and COVID-19: Evidence From United States Medicare Beneficiaries in 2020. Front Clin Diabetes Healthc 2022;3. [DOI: 10.3389/fcdhc.2022.920478] [Reference Citation Analysis]
51 mimouni H, Bouchlarhem A, Lafkih A, Haddar L, Lamzouri O, Bkiyar H, Housni B. Factors influencing the length of stay in the moroccan intensive care unit in patients surviving critical COVID-19 infection. Annals of Medicine and Surgery 2022;79:104108. [DOI: 10.1016/j.amsu.2022.104108] [Reference Citation Analysis]
52 Panda M, Kalita E, Singh S, Kumar K, Rao A, Prajapati VK. MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies. Life Sci 2022;:120761. [PMID: 35787998 DOI: 10.1016/j.lfs.2022.120761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Toniutto P, Falleti E, Cmet S, Cussigh A, Veneto L, Bitetto D, Fornasiere E, Fumolo E, Fabris C, Sartor A, Peressutti R, Curcio F, Regattin L, Grillone L. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients. J Hepatol 2022;77:152-62. [PMID: 35283215 DOI: 10.1016/j.jhep.2022.02.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
54 Koufakis T, Kotsa K, Papanas N. Remission of type 2 diabetes depends on prompt comprehensive lifestyle changes upon diagnosis: How can this "Road to Damascus" experience be supported? J Integr Med 2022;20:288-91. [PMID: 35430168 DOI: 10.1016/j.joim.2022.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Ashour A. The Impact of SARS-CoV-2 on Type 2 Diabetic Individuals: A Review of Current Evidence. JMAHS 2022. [DOI: 10.37881/jmahs.115] [Reference Citation Analysis]
56 Christanto AG, Komala Dewi D, Nugraha HG, Hikmat IH. Chest X-Ray pattern and lung severity score in COVID-19 patients with diabetes mellitus: A cross sectional study. Clin Epidemiol Glob Health 2022;:101107. [PMID: 35781928 DOI: 10.1016/j.cegh.2022.101107] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Rosa L, Vincenzo M, Annalisa C, Federica I, Giordano S, Giada P, Marco P, Irene M, Beatrice M, Elisa F, Matteo C, Alessandra B, Luca V, Flora P, Nicola M, Marina B, Ludovica FA. Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity. Intern Emerg Med 2022. [PMID: 35754075 DOI: 10.1007/s11739-022-03000-1] [Reference Citation Analysis]
58 Setz C, Große M, Auth J, Fröba M, Rauch P, Bausch A, Wright M, Schubert U. Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. Int J Mol Sci 2022;23:6830. [PMID: 35743273 DOI: 10.3390/ijms23126830] [Reference Citation Analysis]
59 Schmid F, Schmitt A, Hermanns N, Kulzer B, Ehrmann D. Psychosocial Impact of the COVID-19 Pandemic on People With Type 1 Diabetes: Results of an Ecological Momentary Assessment Study. Front Clin Diabetes Healthc 2022;3. [DOI: 10.3389/fcdhc.2022.834643] [Reference Citation Analysis]
60 Sassi FC, Ritto AP, de Lima MS, Valente Junior CN, Cardoso PFG, Zilberstein B, Saldiva PHN, de Andrade CRF. Characteristics of postintubation dysphagia in ICU patients in the context of the COVID-19 outbreak: A report of 920 cases from a Brazilian reference center. PLoS ONE 2022;17:e0270107. [DOI: 10.1371/journal.pone.0270107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Al-Taie A, Arueyingho O, Khoshnaw J, Hafeez A. Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation. Arch Physiol Biochem 2022;:1-19. [PMID: 35704400 DOI: 10.1080/13813455.2022.2086265] [Reference Citation Analysis]
62 Boyuk B, Akin S, Aladag N, Isik A, Erman H, Ozgur Y, Topal M, Karademir N, Tomar Uysal B, Ozbilgehan B, Kabaca D, Kalmaz C, Arslan S, Keskin O. COVID-19 pneumonia in patients with impaired fasting glucose, newly diagnosed diabetes and pre-existing diabetes: a tertiary center experience. J Investig Med 2022:jim-2022-002363. [PMID: 35654475 DOI: 10.1136/jim-2022-002363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Tang SW, Leonard BE, Helmeste DM. Long COVID, neuropsychiatric disorders, psychotropics, present and future. Acta Neuropsychiatr 2022;34:109-26. [PMID: 35144718 DOI: 10.1017/neu.2022.6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
64 El‐hayek E, Kahwagi G, Issy N, Tawil C, Younis N, Abou‐khalil R, Matar M, Hallit S. ‎Factors associated with coronavirus disease 2019 infection severity among a sample of Lebanese adults: Data from a cross‐sectional study. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.654] [Reference Citation Analysis]
65 Parthymou A, Habeos EE, Habeos GI, Deligakis A, Livieratos E, Marangos M, Chartoumpekis DV. Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece. BMJ Open 2022;12:e057084. [PMID: 35589363 DOI: 10.1136/bmjopen-2021-057084] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Khatib MY, Ananthegowda DC, Elshafei MS, El‐zeer H, Abdaljawad WI, Shaheen MA, Ibrahim AS, Abujaber AA, Soliman AA, Mohamed AS, Al‐wraidat M, Ahmed A, Nashwan AJ, Saad MO, Butt AA, Al‐maslamani MA, Al‐mohammed A. Predictors of mortality and morbidity in critically ill COVID‐19 patients: An experience from a low mortality country. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Simushi P, Zambwe M, Chipimo P. CHARACTERISTICS AND OUTCOMES OF INDIVIDUALS WITH COVID-19: EVIDENCE FROM A HOSPITAL BASED STUDY.. [DOI: 10.1101/2022.05.13.22274812] [Reference Citation Analysis]
68 Aloul KM, Nielsen JE, Defensor EB, Lin JS, Fortkort JA, Shamloo M, Cirillo JD, Gombart AF, Barron AE. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Front Immunol 2022;13:880961. [DOI: 10.3389/fimmu.2022.880961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Arora S, Singh A, Kumar V, Mohan B, Mahajan R, Singh N, Singh P, Mittal N, Sethi S, Sharma S, Kalra S, Kapoor N, Goyal S. Endocrine and Metabolic Manifestations of COVID-19 Patients Admitted to an Intensive Care Unit. Cureus 2022. [DOI: 10.7759/cureus.24702] [Reference Citation Analysis]
70 Plummer MP, Rait L, Finnis ME, French CJ, Bates Ccrn S, Douglas J, Bhurani M, Broadley T, Trapani T, Deane AM, Udy AA, Burrell AJ, Burrell A, Cheng A, Udy A, Palermo A, Reddi B, Reynolds C, French C, Cooper DJ, Litton E, Begum H, Campbell L, Ramanan M, Plummer M, Mcallister R, Erickson S, Broadley T, Trapani T, Cheung W, Sprint-sari Australia Investigators T, Visser A, Mattke A, Regli A, Rashid A, Tabah A, Walker A, Cheng A, Corley A, Udy A, Ramnani A, Eidan A, Dekeulenaer B, Reddi B, Richards B, Knott C, Moore C, Delzoppo C, Boschert C, Tacon C, French C, Austin D, Brewster D, Cooper D, Crosbie D, Hawkins D, Jessen E, Martinez E, Fysh E, Litton E, Oberender F, Mcgain F, Salt G, Eastwood G, Taori G, White H, Buscher H, Seppelt I, Leditschke IA, Young J, Lavana J, Cohen J, Lugsdin J, Botha J, Santamaria J, Barrett J, Singh K, Laupland K, El-khawas K, Estensen K, Deshpande K, White K, Fitzpatrick L, Campbell L, Ramanan M, Saxena M, Kainer M, Kol M, Page M, Plummer M, Sterba M, Anstey M, Brain M, Maiden M, Kilminster M, Hammond N, Bhadange N, Humphreys N, Jain P, Azzi P, Secombe P, Lister P, Chan P, Mccanny P, Britton P, Janin P, Krishnamurthy R, Sonawane R, Tiruvoipati R, Totaro R, Bellomo R, Sanghavi R, Bates S, Peake S, Bihari S, George S, Erickson S, Webb S, Arora S, Ganu S, Rozen T, Mckenna T, Kadam U, Nayyar V, Choy WH, Albassam W, Data entry at the nested cohort sites, Morgan R, Prasad L, Carstens L, Bates S, Rait L, Bhurani M. Diabetes mellitus, glycaemic control and severe COVID-19 in the Australian Critical Care Setting – a nested cohort study. Australian Critical Care 2022. [DOI: 10.1016/j.aucc.2022.05.002] [Reference Citation Analysis]
71 Fauvel C, Trimaille A, Weizman O, Pezel T, Mika D, Waldmann V, Cohen A, Bonnet G. Cardiovascular manifestations secondary to COVID-19: A narrative review. Respir Med Res 2022;81:100904. [PMID: 35525097 DOI: 10.1016/j.resmer.2022.100904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Pachpande V, Senapathi SHV, Williams K, Chai S, Mandal S, Prabhu S. Demographics, comorbidities, and laboratory parameters in hospitalized patients with SARS-CoV2 infection at a community hospital in rural Pennsylvania. PLoS ONE 2022;17:e0267468. [DOI: 10.1371/journal.pone.0267468] [Reference Citation Analysis]
73 Alam MT, Mehdi A, Timsaal Y, Rehan M, Kumar A, Shaikh IS, Yasmin F, Memon GM, Ahmed N, Asghar MS. The clinical course, biochemical markers, and clinical outcomes of COVID-19 positive patients from the third wave in Pakistan: A retrospective cohort study. Ann Med Surg (Lond) 2022;77:103599. [PMID: 35464609 DOI: 10.1016/j.amsu.2022.103599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Said KB, Alsolami A, Alshammari F, Alreshidi FS, Fathuldeen A, Alrashid F, Bashir AI, Osman S, Aboras R, Alshammari A, Alshammari T, Alharbi SF; on behalf of the Ha’il COM Research Unit Group. Selective COVID-19 Coinfections in Diabetic Patients with Concomitant Cardiovascular Comorbidities Are Associated with Increased Mortality. Pathogens 2022;11:508. [DOI: 10.3390/pathogens11050508] [Reference Citation Analysis]
75 Qeadan F, Tingey B, Egbert J, Pezzolesi MG, Burge MR, Peterson KA, Honda T. The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data. PLoS One 2022;17:e0266809. [PMID: 35439266 DOI: 10.1371/journal.pone.0266809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
76 Kodsup P, Godebo TR. Disparities in Underlying Health Conditions and COVID-19 Infection and Mortality in Louisiana, USA. J Racial Ethn Health Disparities 2022. [PMID: 35445324 DOI: 10.1007/s40615-022-01268-9] [Reference Citation Analysis]
77 Deveci B, Döşemeci L, Aslan A, Asal G, Üstün B, Yildirmer Akar M, Toptas T, Yavuz Taşlipinar M, Saba R. Determinants of clinical course and mortality in COVID-19 patients with hematological disorders: real life data from a single center. The European Research Journal 2022. [DOI: 10.18621/eurj.1000067] [Reference Citation Analysis]
78 Pleym K, Iversen MM, Broström A. Experiences and actions related to living with type 1 diabetes during the COVID-19 pandemic in Norway: a qualitative study conducted during July to December 2020. BMJ Open 2022;12:e056027. [PMID: 35393314 DOI: 10.1136/bmjopen-2021-056027] [Reference Citation Analysis]
79 Pinchera B, Scotto R, Buonomo A, Zappulo E, Stagnaro F, Gallicchio A, Viceconte G, Sardanelli A, Mercinelli S, Villari R, Foggia M, Gentile I. Diabetes and COVID-19: The potential role of mTOR. Diabetes Research and Clinical Practice 2022;186:109813. [DOI: 10.1016/j.diabres.2022.109813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Sinaga BYM, Sinaga JP, Siagian P. Multidrug-resistant Tuberculosis and COVID-19 Coinfection with Diabetes Mellitus in Medan, Indonesia: A Case Report. Open Access Maced J Med Sci 2022;10:187-190. [DOI: 10.3889/oamjms.2022.8817] [Reference Citation Analysis]
81 Saluja G, Bhari A, Pushker N, Agrawal S, Meel R, Thakar A, Xess I, Khandelwal A, Narwal A, Bajaj MS. Experience on rhino-orbital mucormycosis from a tertiary care hospital in the first wave of COVID-19: An Indian perspective. Medical Journal Armed Forces India 2022. [DOI: 10.1016/j.mjafi.2022.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Balik AÖ, Yağci B. Quantitative computerized tomography evaluation of the effects of COVID-19 pneumonia on lung volume. Cukurova Medical Journal 2022;47:415-25. [DOI: 10.17826/cumj.1030243] [Reference Citation Analysis]
83 Bokhary DH, Bokhary NH, Seadawi LE, Moafa AM, Khairallah HH, Bakhsh A. The Role of Demographic, Clinical, and Laboratory Characteristics in Predicting the In-Hospital Outcomes of Patients With COVID-19. Cureus 2022. [DOI: 10.7759/cureus.23418] [Reference Citation Analysis]
84 Rahman M, Hasan MK. Movement restriction during the COVID-19 lockdown and uncontrolled diabetes. Public Health Toxicol 2022;2:1-2. [DOI: 10.18332/pht/146561] [Reference Citation Analysis]
85 Montazeri M, Keykhaei M, Rashedi S, Karbalai Saleh S, Pazoki M, Hadadi A, Sharifnia SH, Sotoodehnia M, Ajloo S, Kafan S, Ashraf H. Prognostic significance of CHADS 2 and CHA 2 DS 2 -VASc scores to predict unfavorable outcomes in hospitalized patients with COVID-19. J Cardiovasc Thorac Res 2022;14:23-33. [DOI: 10.34172/jcvtr.2022.07] [Reference Citation Analysis]
86 Wijayasinghe YS, Bhansali MP, Borkar MR, Chaturbhuj GU, Muntean BS, Viola RE, Bhansali PR. A Comprehensive Biological and Synthetic Perspective on 2-Deoxy-d-Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials. J Med Chem 2022;65:3706-28. [PMID: 35192360 DOI: 10.1021/acs.jmedchem.1c01737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Yousif M, Abd El-raheem G, Mohamed D. Use of Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19) infection among Sudanese patients: a case series. F1000Res 2021;10:512. [DOI: 10.12688/f1000research.51375.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Hrncir T. Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. Microorganisms 2022;10:578. [DOI: 10.3390/microorganisms10030578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Greenwald HP, Tao E, Tilley G. Farmers’ Market Incentives for Low-Income Families: Who Uses, How Much, and Why. American Journal of Preventive Medicine 2022. [DOI: 10.1016/j.amepre.2021.11.023] [Reference Citation Analysis]
90 Corcillo A, Saqib A, Sithamparanathan N, Khanam A, Williams J, Gulati A, Kariyawasam D, Karalliedde J, Pitocco D. Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection. International Journal of Endocrinology 2022;2022:1-6. [DOI: 10.1155/2022/8030765] [Reference Citation Analysis]
91 Liu A, Raja xavier J, Singh Y, Brucker SY, Salker MS. Molecular and Physiological Aspects of SARS-CoV-2 Infection in Women and Pregnancy. Front Glob Womens Health 2022;3:756362. [DOI: 10.3389/fgwh.2022.756362] [Reference Citation Analysis]
92 O’donnell MB, Hilliard ME, Cao VT, Bradford MC, Barton KS, Hurtado S, Duran B, Perez SG, Rahman KS, Scott S, Malik FS, Desalvo DJ, Pihoker C, Zhou C, Rosenberg AR, Yi-frazier JP. “It Just Kind of Feels Like a Different World Now:” Stress and Resilience for Adolescents With Type 1 Diabetes in the Era of COVID-19. Front Clin Diabetes Healthc 2022;3:835739. [DOI: 10.3389/fcdhc.2022.835739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Gajecki D, Doroszko A, Trocha M, Giniewicz K, Kujawa K, Skarupski M, Gawryś J, Matys T, Szahidewicz-Krupska E, Rola P, Stachowska B, Halupczok-Żyła J, Adamik B, Kaliszewski K, Kilis-Pstrusinska K, Letachowicz K, Matera-Witkiewicz A, Pomorski M, Protasiewicz M, Madziarski M, Konikowska K, Remiorz A, Orłowska M, Proc K, Szymala-Pedzik M, Zorawska J, Lindner K, Sokołowski J, Jankowska EA, Madziarska K. Usefulness of the C2HEST Score in Predicting the Clinical Outcomes of COVID-19 in Diabetic and Non-Diabetic Cohorts. J Clin Med 2022;11:873. [PMID: 35160324 DOI: 10.3390/jcm11030873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Kianfar N, Mesgari MS, Mollalo A, Kaveh M. Spatio-temporal modeling of COVID-19 prevalence and mortality using artificial neural network algorithms. Spat Spatiotemporal Epidemiol 2022;40:100471. [PMID: 35120681 DOI: 10.1016/j.sste.2021.100471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
95 Steenblock C, Hoffmann C, Rachner TD, Guggenbichler F, Tahirukaj E, Bejtullah S, Zinserling VA, Varga Z, Bornstein SR, Perakakis N. Management von Diabetespatienten in der COVID-19-Pandemie. Diabetes aktuell 2022;20:43-50. [DOI: 10.1055/a-1754-9194] [Reference Citation Analysis]
96 Ahmed SMJ, Awadelgeed BA, Miskeen E. Assessing the Psychological Impact of the Pandemic COVID -19 in Uninfected High-Risk Population. JMDH 2022;Volume 15:391-9. [DOI: 10.2147/jmdh.s350306] [Reference Citation Analysis]
97 Anaya-covarrubias JY, Pizuorno A, Mirazo S, Torres-flores J, Du Pont G, Lamoyi E, Fierro NA. COVID-19 in Latin America and the Caribbean Region: Symptoms and Morbidities in the Epidemiology of Infection. Current Opinion in Pharmacology 2022. [DOI: 10.1016/j.coph.2022.102203] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Watanabe T; Office HAT Inc. ORIC 321, 5303 Haga, Kita-ku, Okayama, Okayama 701-1221, Japan. Countermeasures Against COVID-19 from the Viewpoints of Dental Diseases: Strengthening Innate Immunity with the Toothpick Method of Brushing. JDR 2022;17:82-6. [DOI: 10.20965/jdr.2022.p0082] [Reference Citation Analysis]
99 Singh AK, Khunti K. COVID-19 and Diabetes. Annu Rev Med 2022;73:129-147. [DOI: 10.1146/annurev-med-042220-011857] [Cited by in Crossref: 11] [Article Influence: 11.0] [Reference Citation Analysis]
100 Pooyan Afzali H, Ali Khani J, Gholamreza I, Saeed H, Hadis Safaei M, Fatemeh Alimohammadi R, Sahar A. COVID-19 and diabetes mellitus patients. Glob J Obes Diabetes Metab Syndr 2022;9:007-010. [DOI: 10.17352/2455-8583.000055] [Reference Citation Analysis]
101 Bonakdaran S, Layegh P, Hasani S, Afkhamizadeh M, Khorasani ZM, Mohebbi M, Vojouhi S, Mousavi Z, Aboutorabi RB, Mehrad-majd H, Sahebkar A, Yaghoubi MA, Sainaghi PP. The Prognostic Role of Metabolic and Endocrine Parameters for the Clinical Severity of COVID-19. Disease Markers 2022;2022:1-8. [DOI: 10.1155/2022/5106342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
102 Usman A, Bliden KP, Cho A, Walia N, Jerjian C, Singh A, Kundan P, Duhan S, Tantry US, Gurbel PA. Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes. J Thromb Thrombolysis 2022. [PMID: 35041121 DOI: 10.1007/s11239-022-02631-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
103 Tu B, Lakoh S, Xu B, Lado M, Cole R, Chu F, Hastings-spaine S, Jalloh MB, Zheng J, Chen W, Sevalie S. Risk Factors for Severity and Mortality in Adult Patients Confirmed with COVID-19 in Sierra Leone: A Retrospective Study. Infectious Diseases & Immunity 2022;2:83-92. [DOI: 10.1097/id9.0000000000000037] [Reference Citation Analysis]
104 Paul AK, Hossain MK, Mahboob T, Nissapatorn V, Wilairatana P, Jahan R, Jannat K, Bondhon TA, Hasan A, de Lourdes Pereira M, Rahmatullah M. Does Oxidative Stress Management Help Alleviation of COVID-19 Symptoms in Patients Experiencing Diabetes? Nutrients 2022;14:321. [PMID: 35057501 DOI: 10.3390/nu14020321] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
105 Erdoğan A, Erdoğan H. Retrospective analysis of clinical features in hospitalized COVID-19 cases in Alanya. Akd Tıp D 2022. [DOI: 10.53394/akd.956513] [Reference Citation Analysis]
106 Mancia G, Rea F, Grassi G, Kjeldsen SE, Kreutz R, Corrao G. COVID-19 and Antihypertensive Treatment. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_18] [Reference Citation Analysis]
107 Balta Başı N, Metin S, Acar Sevinç S, Peker N, Çınar AS, Salkaya A, Altuntaş Y, Özdemir HM. The Effect of Diabetes Mellitus on Mortality in Patients Hospitalized Intensive Care Unit in Covid-19 Pandemic. Acta Biomed 2022;93:e2022068. [PMID: 35775782 DOI: 10.23750/abm.v93i3.11880] [Reference Citation Analysis]
108 Sonkar G, Singh S, Sonkar S. A systematic review approach in understanding the COVID-19 mechanism in diabetes and its progression to diabetic microvascular complications. J Diabetol 2022;13:322. [DOI: 10.4103/jod.jod_87_22] [Reference Citation Analysis]
109 Khan F, Paladino L, Sinert R. The impact of COVID-19 on Diabetic Ketoacidosis patients. Diabetes Metab Syndr 2022;16:102389. [PMID: 35016042 DOI: 10.1016/j.dsx.2022.102389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
110 Gorjão R, Hirabara S, Masi L, Serdan T, Gritte R, Hatanaka E, Souza-siqueira T, Pithon-curi A, Lima TD, Pithon-curi T, Marchini J, Machado M, Souza H, Curi R. Poor prognosis indicators of type-2 diabetic COVID-19 patients. Braz J Med Biol Res 2022;55:e11819. [DOI: 10.1590/1414-431x2022e11819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Souza SMD, Quintão APDC, Soares MCB, Mendes IR, Freitas BACD, Siman AG, Toledo LV. Survival of patients with diabetes mellitus hospitalized for acute respiratory syndrome due to COVID-19. Rev Inst Med trop S Paulo 2022;64. [DOI: 10.1590/s1678-9946202264074] [Reference Citation Analysis]
112 Saadeh M, Calderón-Larrañaga A, Vetrano DL, von Rosen P, Fratiglioni L, Welmer AK. Associations of pre-pandemic levels of physical function and physical activity with COVID-19-like symptoms during the outbreak. Aging Clin Exp Res 2022;34:235-47. [PMID: 34716912 DOI: 10.1007/s40520-021-02006-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Kaza S, Gupta P, Vaidya R, Nooyi S, Chaudhury N. Effect of COVID-19 lockdown on lifestyle habits and self-care practices of diabetic and hypertensive patients in rural Shimla and Udaipur – Findings from the HealthRise India program. Indian J Public Health 2022;66:466. [DOI: 10.4103/ijph.ijph_1908_21] [Reference Citation Analysis]
114 Garces TS, Sousa GJB, Cestari VRF, Florêncio RS, Damasceno LLV, Pereira MLD, Moreira TMM. Diabetes como um fator associado ao óbito hospitalar por COVID-19 no Brasil, 2020. Epidemiol Serv Saúde 2022;31:e2021869. [DOI: 10.1590/s1679-49742022000100021] [Reference Citation Analysis]
115 Ersoy Z, Cekmen N, Günay Y, Ghavam A, Tufan MS, Şahin İ. Evaluation of coronavirus diseases (COVID-19) in terms of epidemiological and clinical features, comorbidities, diagnostic methods, treatment, and mortality. J Edu Health Promot 2022;11:236. [DOI: 10.4103/jehp.jehp_1328_21] [Reference Citation Analysis]
116 Uppal M, Kaur R, Gupta D, Gupta K. Determinants of COVID-19 disease severity in patients having diabetes. AIP Conference Proceedings 2022. [DOI: 10.1063/5.0080607] [Reference Citation Analysis]
117 Basra R, Whyte M, Karalliedde J, Vas P. What is the impact of microvascular complications of diabetes on severe COVID-19? Microvasc Res 2021;140:104310. [PMID: 34979154 DOI: 10.1016/j.mvr.2021.104310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Ong AN, Tan CC, Cañete MT, Lim BA, Robles J. Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection. J ASEAN Fed Endocr Soc 2021;36:133-41. [PMID: 34966196 DOI: 10.15605/jafes.036.02.20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
119 Zodpey SP, Negandhi H, Kamal VK, Bhatnagar T, Ganeshkumar P, Athavale A, Kadri A, Patel A, Bhagyalaxmi A, Khismatrao D, Theranirajan E, Banumathi G, Singh K, Parameshwari P, Kshirsagar P, Saxena R, Deshpande SG, Satyanand K, Hadke S, Dube S, Subramaniam S, Madan S, Kadam S, Anand T, Jeyashree K, Ponnaiah M, Rana M, Murhekar MV, Reddy D. Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020. PLoS One 2021;16:e0261529. [PMID: 34965276 DOI: 10.1371/journal.pone.0261529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Suksatan W, Prabsangob K, Choompunuch B. Association between Health Literacy, Self-care Behavior, and Blood Sugar Level among Older Patients with Type 2 Diabetes in Rural Thai Communities. Ann Geriatr Med Res 2021. [PMID: 34958731 DOI: 10.4235/agmr.21.0117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
121 Türker F, Ahbab S, Çavuşoğlu Türker B, Ataoğlu E, Öztürk S. Clinical characteristics and outcomes of hospitalized COVID-19 patients with diabetes: A multi-center, retrospective study in Turkey. Cumhuriyet Medical Journal 2021. [DOI: 10.7197/cmj.1017675] [Reference Citation Analysis]
122 Bradley SA, Banach M, Alvarado N, Smokovski I, Bhaskar SMM. Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis. Journal of Diabetes. [DOI: 10.1111/1753-0407.13243] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
123 Al Argan R, Alkhafaji D, Al Elq A, Albaker W, Alqatari S, Alzaki A, Alwaheed A, Al Said A, Bukhari H, Al Warthan S, Zeeshan M, AlRubaish F, AlElq Z, Alsahlawi A, Alalwan M, AlHwiesh A, Alabdrabalnabi FI. The Impact of Diabetes Mellitus and Hyperglycemia on the Severity and Outcome of Patients with COVID-19 Disease: A Single-Center Experience. Int J Gen Med 2021;14:9445-57. [PMID: 34908871 DOI: 10.2147/IJGM.S338800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Sarzani R, Allevi M, Giulietti F, Di Pentima C, Re S, Giordano P, Spannella F. The Identikit of Patient at Risk for Severe COVID-19 and Death: The Dysregulation of Renin-Angiotensin System as the Common Theme. J Clin Med 2021;10:5883. [PMID: 34945176 DOI: 10.3390/jcm10245883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Alfonso-Sanchez JL, Agurto-Ramirez A, Chong-Valbuena MA, De-Jesús-María I, Julián-Paches P, López-Cerrillo L, Piedrahita-Valdés H, Giménez-Azagra M, Martín-Moreno JM. The Influence of Infection and Colonization on Outcomes in Inpatients With COVID-19: Are We Forgetting Something? Front Public Health 2021;9:747791. [PMID: 34869165 DOI: 10.3389/fpubh.2021.747791] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
126 Rao GSNK, Gowthami B, Naveen NR, Samudrala PK. An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19. Curr Res Pharmacol Drug Discov 2021;2:100063. [PMID: 34870158 DOI: 10.1016/j.crphar.2021.100063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
127 Nasa P, Chaudhry D, Govil D, Daga MK, Jain R, Chhallani AA, Krishna A, Jagiasi BG, Juneja D, Barthakur HS, Jha H, Gurjar M, Rangappa P, Aladakatti R, Mishra RC, Shetty RM, Yadav R, Garg S, Nandakumar SM, Samavedam S, Ray S, Hadda V, Javeri Y, Munjal M. Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19. Indian J Crit Care Med 2021;25:1280-5. [PMID: 34866826 DOI: 10.5005/jp-journals-10071-23923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
128 Nasa P, Chaudhry D, Govil D, Daga MK, Jain R, Chhallani AA, Krishna A, Jagiasi BG, Juneja D, Barthakur HS, Jha H, Gurjar M, Rangappa P, Aladakatti R, Mishra RC, Shetty RM, Yadav R, Garg S, Nandakumar SM, Samavedam S, Ray S, Hadda V, Javeri Y, Munjal M. Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19. Indian J Crit Care Med 2021;25:1280-5. [PMID: 34866826 DOI: 10.5005/jp-journals-10071-23923] [Reference Citation Analysis]
129 Wong CKH, Lui DTW, Lui AYC, Kwok ACY, Low MCH, Lau KTK, Au ICH, Xiong X, Chung MSH, Lau EHY, Cowling BJ. Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong. Diabetes Metab 2021;48:101307. [PMID: 34863934 DOI: 10.1016/j.diabet.2021.101307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Rangankar V, Koganti DV, Lamghare P, Prabhu A, Dhulipala S, Patil P, Yadav P. Correlation Between CT Severity Scoring and Diabetes Mellitus in Patients With COVID-19 Infection. Cureus 2021;13:e20199. [PMID: 35004020 DOI: 10.7759/cureus.20199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Aziz F, Aberer F, Bräuer A, Ciardi C, Clodi M, Fasching P, Karolyi M, Kautzky-Willer A, Klammer C, Malle O, Pawelka E, Pieber T, Peric S, Ress C, Schranz M, Sourij C, Stechemesser L, Stingl H, Stöcher H, Stulnig T, Tripolt N, Wagner M, Wolf P, Zitterl A, Reisinger AC, Siller-Matula J, Hummer M, Moser O, von-Lewinski D, Eller P, Kaser S, Sourij H. COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data. Viruses 2021;13:2401. [PMID: 34960670 DOI: 10.3390/v13122401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
132 Li C, Islam N, Gutierrez JP, Lacey B, Moolenaar RL, Richter P. Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis. BMJ Open 2021;11:e051711. [PMID: 34836901 DOI: 10.1136/bmjopen-2021-051711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Tabatabaie M, Sarrami AH, Didehdar M, Tasorian B, Shafaat O, Sotoudeh H. Accuracy of Machine Learning Models to Predict Mortality in COVID-19 Infection Using the Clinical and Laboratory Data at the Time of Admission. Cureus 2021;13:e18768. [PMID: 34804648 DOI: 10.7759/cureus.18768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
134 Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health 2021;8:720-42. [PMID: 34786431 DOI: 10.3934/publichealth.2021057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Deligiorgi MV, Siasos G, Vakkas L, Trafalis DT. Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution. Cancers (Basel) 2021;13:5785. [PMID: 34830939 DOI: 10.3390/cancers13225785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
136 Kabootari M, Habibi Tirtashi R, Hasheminia M, Bozorgmanesh M, Khalili D, Akbari H, Roshandel G, Hadaegh F. Clinical features, risk factors and a prediction model for in-hospital mortality among diabetic patients infected with COVID-19: data from a referral centre in Iran. Public Health 2021;202:84-92. [PMID: 34933204 DOI: 10.1016/j.puhe.2021.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Harbuwono DS, Handayani DOTL, Wahyuningsih ES, Supraptowati N, Ananda, Kurniawan F, Wafa S, Kristanti M, Pantoro NI, Sinto R, Kurniawan H, Rebekka, Tahapary DL. Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta's COVID-19 epidemiological registry. Prim Care Diabetes 2021:S1751-9918(21)00192-3. [PMID: 34857490 DOI: 10.1016/j.pcd.2021.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
138 Kim MJ, Park C, Sharp LK, Quinn L, Bronas UG, Gruss V, Fritschi C. Impact of worries associated with COVID-19 on diabetes-related psychological symptoms in older adults with Type 2 diabetes. Geriatr Nurs 2021;43:58-63. [PMID: 34823078 DOI: 10.1016/j.gerinurse.2021.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
139 Verma A, Patyal A, Mathur M, Choudhary S, Mathur N. Sociodemographic and clinical characteristics associated with COVID mortality among hospitalized patients in Rajasthan: A retrospective observational study. J Family Med Prim Care 2021;10:3319-24. [PMID: 34760751 DOI: 10.4103/jfmpc.jfmpc_445_21] [Reference Citation Analysis]
140 Abd El-Raheem GOH, Mohamed DSI, Yousif MAA, Elamin HES. Characteristics and severity of COVID-19 among Sudanese patients during the waves of the pandemic. Sci Afr 2021;14:e01033. [PMID: 34729446 DOI: 10.1016/j.sciaf.2021.e01033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Kim J, Hong K, Gómez Gómez RE, Kim S, Chun BC. Lack of Evidence of COVID-19 Being a Risk Factor of Alopecia Areata: Results of a National Cohort Study in South Korea. Front Med (Lausanne) 2021;8:758069. [PMID: 34722594 DOI: 10.3389/fmed.2021.758069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
142 Ghadamgahi F, Tapak L, Bashirian S, Amiri R, Roshanaei G. The effect of underlying diabetes disease on clinical outcome and survival in patients with Covid-19: a propensity score matching study. J Diabetes Metab Disord 2021;:1-9. [PMID: 34746038 DOI: 10.1007/s40200-021-00922-z] [Reference Citation Analysis]
143 Pardhan S, Islam MS, López-Sánchez GF, Upadhyaya T, Sapkota RP. Self-isolation negatively impacts self-management of diabetes during the coronavirus (COVID-19) pandemic. Diabetol Metab Syndr 2021;13:123. [PMID: 34715917 DOI: 10.1186/s13098-021-00734-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
144 Zhu Z, Zhang S, Wang P, Chen X, Bi J, Cheng L, Zhang X. A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19. Brief Bioinform 2021:bbab446. [PMID: 34718395 DOI: 10.1093/bib/bbab446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
145 Kantroo V, Kanwar MS, Goyal P, Rosha D, Modi N, Bansal A, Ansari AP, Wangnoo SK, Sobti S, Kansal S, Chawla R, Jasuja S, Gupta I. Mortality and Clinical Outcomes among Patients with COVID-19 and Diabetes. Med Sci (Basel) 2021;9:65. [PMID: 34842758 DOI: 10.3390/medsci9040065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
146 Alhumaid S, Al Mutair A, Al Alawi Z, Rabaan AA, Alomari MA, Al Salman SA, Al-Alawi AS, Al Hassan MH, Alhamad H, Al-Kamees MA, Almousa FM, Mufti HN, Alwesabai AM, Dhama K, Al-Tawfiq JA, Al-Omari A. Diabetic ketoacidosis in patients with SARS-CoV-2: a systematic review and meta-analysis. Diabetol Metab Syndr 2021;13:120. [PMID: 34702335 DOI: 10.1186/s13098-021-00740-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
147 Surma S, Banach M, Lewek J. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection. Lipids Health Dis 2021;20:141. [PMID: 34689776 DOI: 10.1186/s12944-021-01563-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
148 Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, Laouali N, Peiffer-Smadja N, Aune D, Severi G. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open 2021;11:e052777. [PMID: 34697120 DOI: 10.1136/bmjopen-2021-052777] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
149 Paidi RK, Jana M, Raha S, McKay M, Sheinin M, Mishra RK, Pahan K. Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses. J Neuroimmune Pharmacol 2021. [PMID: 34677731 DOI: 10.1007/s11481-021-10028-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
150 Filip R, Anchidin-Norocel L, Gheorghita R, Savage WK, Dimian M. Changes in Dietary Patterns and Clinical Health Outcomes in Different Countries during the SARS-CoV-2 Pandemic. Nutrients 2021;13:3612. [PMID: 34684615 DOI: 10.3390/nu13103612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
151 Alonso-silverio GA, Francisco-garcía V, Guzmán-guzmán IP, Ventura-molina E, Alarcón-paredes A. Toward Non-Invasive Estimation of Blood Glucose Concentration: A Comparative Performance. Mathematics 2021;9:2529. [DOI: 10.3390/math9202529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Karlsson Sundbaum J, Vanfleteren LEGW, Konradsen JR, Nyberg F, Ekberg-Jansson A, Stridsman C. Severe COVID-19 among patients with asthma and COPD: a report from the Swedish National Airway Register. Ther Adv Respir Dis 2021;15:17534666211049738. [PMID: 34623194 DOI: 10.1177/17534666211049738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Sen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases 2021; 9(28): 8327-8339 [PMID: 34754842 DOI: 10.12998/wjcc.v9.i28.8327] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
154 Lami F, Elfadul M, Rashak HA, Al Nsour M, Akhtar H, Khader YS, Hussein AM, Naciri M, Samy S, Ghaleb Y, Taha HA, Aljanabe AH, Ali NA, Zayer RH, Ikram A, Rahman FU, Khan MM, Adam R, Ahmed AY, Afifi S. Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: A Multicountry Retrospective Study . JMIR Public Health Surveill 2021. [PMID: 34736222 DOI: 10.2196/32831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
155 Arango-guerra P, Moncayo-viveros JG, Correa-londoño N, García-roncallo A, Ramírez-escobar L, Sánchez-moreno AM, Pérez-muñoz M, Zuluaga-garcía JP, Dallos-ferrerosa JN, Ramírez-vélez A, Moreno-bedoya S. Crisis hiperglucémica concomitante con infección por SARS-CoV-2: una serie de casos. Acta Colombiana de Cuidado Intensivo 2021;21:338-342. [DOI: 10.1016/j.acci.2021.02.004] [Reference Citation Analysis]
156 Friedrichsen H. Diabetes und COVID-19. Zeitschrift für Orthomolekulare Medizin 2021;19:24-28. [DOI: 10.1055/a-1584-4906] [Reference Citation Analysis]
157 Czupryniak L, Dicker D, Lehmann R, Prázný M, Schernthaner G. The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence? Cardiovasc Diabetol 2021;20:198. [PMID: 34598700 DOI: 10.1186/s12933-021-01389-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Andrade CAS, Paz JLC, de Melo GS, Mahrouseh N, Januário AL, Capeletti LR. Survival rate and peri-implant evaluation of immediately loaded dental implants in individuals with type 2 diabetes mellitus: a systematic review and meta-analysis. Clin Oral Investig 2021. [PMID: 34586502 DOI: 10.1007/s00784-021-04154-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
159 Nyland JE, Raja-Khan NT, Bettermann K, Haouzi PA, Leslie DL, Kraschnewski JL, Parent LJ, Grigson PS. Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study. Diabetes 2021;70:2903-16. [PMID: 34580086 DOI: 10.2337/db21-0385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
160 Sankaranarayanan S, Balan J, Walsh JR, Wu Y, Minnich S, Piazza A, Osborne C, Oliver GR, Lesko J, Bates KL, Khezeli K, Block DR, DiGuardo M, Kreuter J, O'Horo JC, Kalantari J, Klee EW, Salama ME, Kipp B, Morice WG, Jenkinson G. COVID-19 Mortality Prediction From Deep Learning in a Large Multistate Electronic Health Record and Laboratory Information System Data Set: Algorithm Development and Validation. J Med Internet Res 2021;23:e30157. [PMID: 34449401 DOI: 10.2196/30157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
161 Shrestha DB, Budhathoki P, Raut S, Adhikari S, Ghimire P, Thapaliya S, Rabaan AA, Karki BJ. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. World J Virol 2021; 10(5): 275-287 [PMID: 34631477 DOI: 10.5501/wjv.v10.i5.275] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
162 Putri G, Hasyim H, Fajar NA. Analysis of COVID-19 Prevention Behaviour among Diabetes Mellitus Comorbidity Patients in Palembang. JPK 2021;9:168. [DOI: 10.20473/jpk.v9.i2.2021.168-176] [Reference Citation Analysis]
163 Mahoney R, Lee GK, Zepeda JP, Gabriel C, Hall K, Edwards R, Kimonis V. Severe manifestations and treatment of COVID-19 in a transplanted patient with Fabry disease. Mol Genet Metab Rep 2021;29:100802. [PMID: 34545322 DOI: 10.1016/j.ymgmr.2021.100802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Chaudhuri A, Paul S, Ghosh T. Challenges in the Management of COVID-19 Patients with Metabolic Syndrome with Special Emphasis on Gender and Age - A Review. jebmh 2021;8:3401-3405. [DOI: 10.18410/jebmh/2021/617] [Reference Citation Analysis]
165 Yamamotoya T, Nakatsu Y, Kanna M, Hasei S, Ohata Y, Encinas J, Ito H, Okabe T, Asano T, Sakaguchi T. Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic target. Sci Rep 2021;11:18581. [PMID: 34535740 DOI: 10.1038/s41598-021-97972-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
166 Amini-Farsani Z, Yadollahi-Farsani M, Arab S, Forouzanfar F, Yadollahi M, Asgharzade S. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways. Int Immunopharmacol 2021;100:108071. [PMID: 34482267 DOI: 10.1016/j.intimp.2021.108071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
167 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
168 Parthymou A, Habeos EE, Habeos GI, Deligakis A, Livieratos E, Marangos M, Chartoumpekis DV. Sars-Cov-2 antibody titer 3 months post-vaccination is affected by age, gender, smoking and vitamin D.. [DOI: 10.1101/2021.09.01.21262913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
169 Chouhan M, Solanki B, Shakrawal N. Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemic. J Laryngol Otol 2021;135:981-6. [PMID: 34470691 DOI: 10.1017/S0022215121002309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
170 Karonova TL, Andreeva AT, Golovatuk KA, Bykova ES, Simanenkova AV, Vashukova MA, Grant WB, Shlyakhto EV. Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19. Nutrients 2021;13:3021. [PMID: 34578898 DOI: 10.3390/nu13093021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
171 Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, Koch J, Nygren T, Scholz S, Schönfeld V, Vygen-Bonnet S, Wichmann O, Harder T. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med 2021;19:212. [PMID: 34446016 DOI: 10.1186/s12916-021-02058-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 15.5] [Reference Citation Analysis]
172 Selek A, Gezer E, Altun E, Sözen M, Topaloğlu Ö, Köksalan D, Demirkan H, Karakaya D, Cetinarslan B, Cantürk Z, Taymez D. The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli. J Diabetes Metab Disord 2021;:1-7. [PMID: 34466406 DOI: 10.1007/s40200-021-00888-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
173 Rehman FU, Omair SF, Memon F, Rind BJ, Memon DA, Ali SA, Ahmed B, Ali N. The Relation of ABO Blood Group to the Severity of Coronavirus Disease: A Cross-Sectional Study From a Tertiary Care Hospital in Karachi. Cureus 2021;13:e16598. [PMID: 34430180 DOI: 10.7759/cureus.16598] [Reference Citation Analysis]
174 Kim SW, Jeon JH, Moon JS, Kim MK. High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study. Endocrinol Metab (Seoul) 2021;36:800-9. [PMID: 34418914 DOI: 10.3803/EnM.2021.1040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
175 Caycho-Rodríguez T, Vilca LW, Corrales-Reyes IE, Hernández-García F, Pérez AP, Quintana PG, Pérez García ER, Lazo Herrera LA, White M. COVID-19 contagion concern scale (PRE-COVID-19): Validation in Cuban patients with type 2 diabetes. Diabetes Metab Syndr 2021;15:102245. [PMID: 34416467 DOI: 10.1016/j.dsx.2021.102245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
176 Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 2021;21:855. [PMID: 34418980 DOI: 10.1186/s12879-021-06536-3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 109] [Article Influence: 46.0] [Reference Citation Analysis]
177 Jayaswal SK, Singh S, Malik PS, Venigalla SK, Gupta P, Samaga SN, Hota RN, Bhatia SS, Gupta I. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India. Diabetes Metab Syndr 2021;15:102248. [PMID: 34412000 DOI: 10.1016/j.dsx.2021.102248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
178 Wang W, Sun Y, Wang S, Sun Y. The Relationship Between Insulin Use And Increased Mortality In Patients With COVID-19 And Diabetes: A Meta-Analysis. Endocr Res 2021;:1-7. [PMID: 34409914 DOI: 10.1080/07435800.2021.1967376] [Reference Citation Analysis]
179 Binhardi BA, de Souza Teixeira CR, de Almeida-Pititto B, Barbosa-Junior F, Franco LJ, de Melo KFS, Malerbi DAC, de Oliveira REM. Diabetes self-care practices and resilience in the Brazilian COVID-19 pandemic: results of a web survey: DIABETESvid. Diabetol Metab Syndr 2021;13:87. [PMID: 34412660 DOI: 10.1186/s13098-021-00706-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
180 Lami F, Elfadul M, Rashak H, Al Nsour M, Akhtar H, Khader Y, Hussein AM, Naciri M, Samy S, Ghaleb Y, Taha H, Hussein A, Ali NA, Hussein R, Ikram A, Rahman FU, Khan MM, Adam R, Ahmed AY, Afifi S. Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: Multicountry Retrospective Study (Preprint).. [DOI: 10.2196/preprints.32831] [Reference Citation Analysis]
181 Sundaram ME, Calzavara A, Mishra S, Kustra R, Chan AK, Hamilton MA, Djebli M, Rosella LC, Watson T, Chen H, Chen B, Baral SD, Kwong JC. Déterminants individuels et sociaux du test de dépistage du SRAS-CoV-2 et de l’obtention d’un résultat positif en Ontario, au Canada: une étude populationnelle. CMAJ 2021;193:E1261-76. [PMID: 34400488 DOI: 10.1503/cmaj.202608-f] [Reference Citation Analysis]
182 Roos M, Hunanyan S, Bakka H, Rue H. Sensitivity and identification quantification by a relative latent model complexity perturbation in Bayesian meta-analysis. Biom J 2021. [PMID: 34378223 DOI: 10.1002/bimj.202000193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Poly TN, Islam MM, Li YJ, Lin MC, Hsu MH, Wang YC. Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism. J Clin Med 2021;10:3507. [PMID: 34441802 DOI: 10.3390/jcm10163507] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
184 Rizvi AA, Stoian AP, Lessan N, Rizzo M. Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care. Medicina (Kaunas) 2021;57:805. [PMID: 34441011 DOI: 10.3390/medicina57080805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
185 El-masry OS. Simple statistical insights into the COVID-19 data of Saudi Arabia: figures prior to vaccination campaign. F1000Res 2021;10:410. [DOI: 10.12688/f1000research.52600.2] [Reference Citation Analysis]
186 Ilias I, Koukkou E. Hyperglycémie, hydroxychloroquine et SARS-CoV-2. La Presse Médicale Formation 2021;2:229. [DOI: 10.1016/j.lpmfor.2021.01.007] [Reference Citation Analysis]
187 Joensen LE, Steenberg JL, Madsen KP, Willaing I. What people with diabetes in Denmark worry about during the COVID-19 pandemic: A longitudinal study of the first 3 months of the COVID-19 pandemic. Diabet Med 2021;:e14665. [PMID: 34327749 DOI: 10.1111/dme.14665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
188 Stevens JS, Bogun MM, McMahon DJ, Zucker J, Kurlansky P, Mohan S, Yin MT, Nickolas TL, Pajvani UB. Diabetic ketoacidosis and mortality in COVID-19 infection. Diabetes Metab 2021;47:101267. [PMID: 34332112 DOI: 10.1016/j.diabet.2021.101267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
189 Qian S, Faithfull J, Sangster P, Butler G, Srirangalingam U. Klinefelter syndrome-Considerations in management during the SARS-CoV-2 pandemic. Clin Endocrinol (Oxf) 2023;98:131-2. [PMID: 34309060 DOI: 10.1111/cen.14553] [Reference Citation Analysis]
190 Hirschbühl K, Dintner S, Beer M, Wylezich C, Schlegel J, Delbridge C, Borcherding L, Lippert J, Schiele S, Müller G, Moiraki D, Spring O, Wittmann M, Kling E, Braun G, Kröncke T, Claus R, Märkl B, Schaller T. Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approach. PLoS One 2021;16:e0254872. [PMID: 34280238 DOI: 10.1371/journal.pone.0254872] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
191 Estedlal A, Jeddi M, Heydari ST, Jahromi MG, Dabbaghmanesh MH. Impacts of diabetes mellitus on clinical and para-clinical parameters among COVID-19 patients. J Diabetes Metab Disord 2021;:1-9. [PMID: 34277497 DOI: 10.1007/s40200-021-00844-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Iqbal A, Greig M, Arshad MF, Julian TH, Ee Tan S, Elliott J. Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K. Diabetes Res Clin Pract 2021;178:108955. [PMID: 34273452 DOI: 10.1016/j.diabres.2021.108955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Magdy Beshbishy A, Oti VB, Hussein DE, Rehan IF, Adeyemi OS, Rivero-Perez N, Zaragoza-Bastida A, Shah MA, Abouelezz K, Hetta HF, Cruz-Martins N, Batiha GE. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review. Front Public Health 2021;9:591982. [PMID: 34307267 DOI: 10.3389/fpubh.2021.591982] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
194 Kuzeytemiz M. Does Hypertension Alone Increase Mortality In Young Hypertensive Patients With COVİD-19? Single Center Retrospective Study Of 100 Patients. Ahi Evran Medical Journal 2021. [DOI: 10.46332/aemj.845972] [Reference Citation Analysis]
195 Yousif M, Abd El-raheem G, Mohamed D. Use of remdesivir in the treatment of coronavirus disease 2019 (COVID-19) infection among Sudanese patients: a case series. F1000Res 2021;10:512. [DOI: 10.12688/f1000research.51375.1] [Reference Citation Analysis]
196 Farber PL. Can erythrocytes behavior in microcirculation help the understanding the physiopathology and improve prevention and treatment for covid-19? Clin Hemorheol Microcirc 2021;78:41-7. [PMID: 33523046 DOI: 10.3233/CH-201082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
197 Landstra CP, de Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol (Lausanne) 2021;12:649525. [PMID: 34220706 DOI: 10.3389/fendo.2021.649525] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 23.0] [Reference Citation Analysis]
198 Kar S, Chawla R, Haranath SP, Ramasubban S, Ramakrishnan N, Vaishya R, Sibal A, Reddy S. Multivariable mortality risk prediction using machine learning for COVID-19 patients at admission (AICOVID). Sci Rep 2021;11:12801. [PMID: 34140592 DOI: 10.1038/s41598-021-92146-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
199 Bhatt KP, Quinonez J, Patel A, Patel M, Mohamed A, Aziz MA, Venkataramani D, Zohora F, Hange N, Awad D, Mehta I, Domingo PIM, Jamil N, Kandi SR, Thevuthasan S, Khawaja UA, Baskaran D, Banks L, Michel G, Sanchez-gonzalez M. COVID-19 Pathophysiology and Clinical Effects on Multiple Organ Systems - A Narrative Review. Int Ann Sci 2021;10:151-167. [DOI: 10.21467/ias.10.1.151-167] [Reference Citation Analysis]
200 Tarazi WW, Finegold K, Sheingold SH, Wong Samson L, Zuckerman R, Bosworth A. COVID-19-Related Deaths And Excess Deaths Among Medicare Fee-For-Service Beneficiaries. Health Aff (Millwood) 2021;40:879-85. [PMID: 34097514 DOI: 10.1377/hlthaff.2020.02521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
201 Dilogo IH, Aditianingsih D, Sugiarto A, Burhan E, Damayanti T, Sitompul PA, Mariana N, Antarianto RD, Liem IK, Kispa T, Mujadid F, Novialdi N, Luviah E, Kurniawati T, Lubis AMT, Rahmatika D. Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial. Stem Cells Transl Med 2021. [PMID: 34102020 DOI: 10.1002/sctm.21-0046] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 21.0] [Reference Citation Analysis]
202 Park SD, Kim NY, Jeon JH, Kim JG, Lee IK, Park KG, Choi YK. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes. Korean J Intern Med 2021;36:942-8. [PMID: 34092049 DOI: 10.3904/kjim.2020.464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
203 Wallett L, Kempegowda P, Melson E, Juszczak A, Thomas L, Zhou D, Holmes C, Karamat MA, Ghosh S, Hanif W, Johnson A, Narendran P, Bellary S. Differences in presentation, severity and management of DKA in type 1 and type 2 diabetes during the COVID-19 pandemic. Clin Med (Lond) 2021;21:1-2. [PMID: 34078672 DOI: 10.7861/clinmed.21-2-s1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
204 Fillmore NR, La J, Szalat RE, Tuck DP, Nguyen V, Yildirim C, Do NV, Brophy MT, Munshi NC. Prevalence and outcome of COVID-19 infection in cancer patients: a national Veterans Affairs study. J Natl Cancer Inst. 2020;. [PMID: 33031532 DOI: 10.1093/jnci/djaa159] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 22.0] [Reference Citation Analysis]
205 Mehta PB, Kohn MA, Koliwad SK, Rushakoff RJ. Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetes. BMJ Open Diabetes Res Care 2021;9:e002203. [PMID: 34059527 DOI: 10.1136/bmjdrc-2021-002203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
206 Harrison J, Hill J, Palmer K. Identifying risk factors for mortality in patients admitted to hospital with COVID-19. British Journal of Cardiac Nursing 2021;16:1-4. [DOI: 10.12968/bjca.2021.0029] [Reference Citation Analysis]
207 Mesenburg MA, Hallal PC, Menezes AMB, Barros AJD, Horta BL, Barros FC, Hartwig FP, Jacques N, Silveira MFD. Chronic non-communicable diseases and COVID-19: EPICOVID-19 Brazil results. Rev Saude Publica 2021;55:38. [PMID: 34105606 DOI: 10.11606/s1518-8787.2021055003673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
208 Hyun JH, Kim MH, Sohn Y, Cho Y, Baek YJ, Kim JH, Ahn JY, Choi JY, Yeom JS, Ahn MY, Kim EJ, Baek JH, Kim YK, Choi H, Jeong SJ. Effects of early corticosteroid use in patients with severe coronavirus disease 2019. BMC Infect Dis 2021;21:506. [PMID: 34058989 DOI: 10.1186/s12879-021-06221-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
209 Raghavan A, Nanditha A, Satheesh K, Susairaj P, Vinitha R, Chandrasekaran S, Palaniappan T, Thillai Vallal S, Subair Khan A, Snehalatha C, Ramachandran A. Profile and prognosis of patients hospitalized for COVID-19 virus infection with and without diabetes - An observational study from South India. Diabetes Metab Syndr 2021;15:102143. [PMID: 34186345 DOI: 10.1016/j.dsx.2021.05.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
210 El-masry OS. Simple statistical insights into the COVID-19 data of Saudi Arabia: figures prior to vaccination campaign. F1000Res 2021;10:410. [DOI: 10.12688/f1000research.52600.1] [Reference Citation Analysis]
211 Affinati AH, Wallia A, Gianchandani RY. Severe hyperglycemia and insulin resistance in patients with SARS-CoV-2 infection: a report of two cases. Clin Diabetes Endocrinol 2021;7:8. [PMID: 33992101 DOI: 10.1186/s40842-021-00121-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
212 Song J, Park DW, Cha JH, Seok H, Kim JY, Park J, Cho H. Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study. Sci Rep 2021;11:10066. [PMID: 33980912 DOI: 10.1038/s41598-021-89548-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
213 Ibrahim S, Monaco GSF, Sims EK. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell. Islets 2021;13:66-79. [PMID: 33970787 DOI: 10.1080/19382014.2021.1909970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
214 Niu Y, Chen Y, Sun P, Wang Y, Luo J, Ding Y, Xie W. Intragastric and atomized administration of canagliflozin inhibit inflammatory cytokine storm in lipopolysaccharide-treated sepsis in mice: A potential COVID-19 treatment. Int Immunopharmacol 2021;96:107773. [PMID: 34020392 DOI: 10.1016/j.intimp.2021.107773] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
215 Kountouri A, Korakas E, Ikonomidis I, Raptis A, Tentolouris N, Dimitriadis G, Lambadiari V. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes. Antioxidants (Basel) 2021;10:752. [PMID: 34065123 DOI: 10.3390/antiox10050752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
216 Sharif N, Ahmed SN, Opu RR, Tani MR, Dewan D, Daullah MU, Shanto RI, Parvez AK, Talukder AA, Dey SK. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh. Diabetes Metab Syndr 2021;15:1009-16. [PMID: 33993046 DOI: 10.1016/j.dsx.2021.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
217 Dincer B, Yıldırım Ayaz E, Oğuz A. Changes in Sexual Functions and Alexithymia Levels of Patients with Type 2 Diabetes During the COVID-19 Pandemic. Sex Disabil 2021;:1-18. [PMID: 33967358 DOI: 10.1007/s11195-021-09693-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
218 Sankaranarayanan S, Balan J, Walsh JR, Wu Y, Minnich S, Piazza A, Osborne C, Oliver GR, Lesko J, Bates KL, Khezeli K, Block DR, Diguardo M, Kreuter J, O’horo JC, Kalantari J, Klee EW, Salama ME, Kipp B, Morice WG, Jenkinson G. COVID-19 Mortality Prediction From Deep Learning in a Large Multistate Electronic Health Record and Laboratory Information System Data Set: Algorithm Development and Validation (Preprint).. [DOI: 10.2196/preprints.30157] [Reference Citation Analysis]
219 De Rosa FG, Palazzo A, Rosso T, Shbaklo N, Mussa M, Boglione L, Borgogno E, Rossati A, Mornese Pinna S, Scabini S, Chichino G, Borrè S, Del Bono V, Garavelli PL, Barillà D, Cattel F, Di Perri G, Ciccone G, Lupia T, Corcione S. Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry. J Clin Med 2021;10:1951. [PMID: 34062864 DOI: 10.3390/jcm10091951] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
220 Sundaram ME, Calzavara A, Mishra S, Kustra R, Chan AK, Hamilton MA, Djebli M, Rosella LC, Watson T, Chen H, Chen B, Baral SD, Kwong JC. Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study. CMAJ 2021;193:E723-34. [PMID: 33906966 DOI: 10.1503/cmaj.202608] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 19.0] [Reference Citation Analysis]
221 Alonso GT, Ebekozien O, Gallagher MP, Rompicherla S, Lyons SK, Choudhary A, Majidi S, Pinnaro CT, Balachandar S, Gangat M, Curda Roberts AJ, Marks BE, Creo A, Sanchez J, Seeherunvong T, Jimenez-Vega J, Patel NS, Wood JR, Gabriel L, Sumpter KM, Wilkes M, Rapaport R, Cymbaluk A, Wong JC, Sanda S, Albanese-O'neill A. Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes. J Diabetes 2021;13:681-7. [PMID: 33855813 DOI: 10.1111/1753-0407.13184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
222 Mohandas P, Periasamy S, Marappan M, Sampath A, Garfin Sundaram VK, Cherian VK. Clinical review of COVID-19 patients presenting to a quaternary care private hospital in South India: A retrospective study. Clin Epidemiol Glob Health 2021;11:100751. [PMID: 33937584 DOI: 10.1016/j.cegh.2021.100751] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
223 Freda CT, Yin W, Ghebrehiwet B, Rubenstein DA. SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts. Clin Immunol 2021;227:108733. [PMID: 33895357 DOI: 10.1016/j.clim.2021.108733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
224 Lopez-Castaneda S, García-Larragoiti N, Cano-Mendez A, Blancas-Ayala K, Damian-Vázquez G, Perez-Medina AI, Chora-Hernández LD, Arean-Martínez C, Viveros-Sandoval ME. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection. Clin Appl Thromb Hemost 2021;27:1076029621999099. [PMID: 33835872 DOI: 10.1177/1076029621999099] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
225 di Filippo L, Doga M, Frara S, Giustina A. Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications. Rev Endocr Metab Disord 2021. [PMID: 33846867 DOI: 10.1007/s11154-021-09655-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
226 Ramphul K, Lohana P, Ramphul Y, Park Y, Mejias S, Dhillon BK, Sombans S, Verma R. Hypertension, diabetes mellitus, and cerebrovascular disease predispose to a more severe outcome of COVID-19. Arch Med Sci Atheroscler Dis 2021;6:e30-9. [PMID: 34027212 DOI: 10.5114/amsad.2021.105255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
227 Lorincz-Comi N, Zhu X. Cardiometabolic risks of SARS-CoV-2 hospitalization using Mendelian Randomization. Sci Rep 2021;11:7848. [PMID: 33846372 DOI: 10.1038/s41598-021-86757-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
228 Vecino-ortiz AI, Guzman-tordecilla N, Ruiz YFG, Peñaloza-quintero RE, Fernández-niño JA, Gomez FR, Trujillo AJ. Development of a tool to prioritize the monitoring of COVID-19 patients by public health teams.. [DOI: 10.1101/2021.04.08.21254922] [Reference Citation Analysis]
229 Buicu AL, Cernea S, Benedek I, Buicu CF, Benedek T. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity. J Clin Med 2021;10:1545. [PMID: 33916917 DOI: 10.3390/jcm10081545] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
230 Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 2021;19:425-41. [PMID: 33824495 DOI: 10.1038/s41579-021-00542-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 80] [Article Influence: 36.5] [Reference Citation Analysis]
231 Magallón-Botaya R, Oliván-Blázquez B, Ramírez-Cervantes KL, Méndez-López-de-la-Manzanara F, Aguilar-Palacio I, Casajuana-Closas M, Andrés-Esteban E. Geographic Factors Associated with Poorer Outcomes in Patients Diagnosed with COVID-19 in Primary Health Care. Int J Environ Res Public Health 2021;18:3842. [PMID: 33917578 DOI: 10.3390/ijerph18073842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
232 Landecho MF, Marin-Oto M, Recalde-Zamacona B, Bilbao I, Frühbeck G. Obesity as an adipose tissue dysfunction disease and a risk factor for infections - Covid-19 as a case study. Eur J Intern Med 2021;91:3-9. [PMID: 33858724 DOI: 10.1016/j.ejim.2021.03.031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
233 Kempegowda P, Melson E, Johnson A, Wallett L, Thomas L, Zhou D, Holmes C, Juszczak A, Karamat MA, Ghosh S, Hanif W, Narendran P, Bellary S. Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes. Endocr Connect 2021;10:371-7. [PMID: 33666571 DOI: 10.1530/EC-20-0567] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
234 Schmidt IM, Verma A, Waikar SS. Circulating plasma angiotensin-converting enzyme 2 concentrations in patients with kidney disease. Eur Heart J 2020;41:3097-8. [PMID: 32691065 DOI: 10.1093/eurheartj/ehaa523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
235 Wu CC, Lee AJ, Su CH, Huang CY, Islam MM, Weng YC. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19. J Clin Med 2021;10:1450. [PMID: 33916281 DOI: 10.3390/jcm10071450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
236 Saha S, Al-Rifai RH, Saha S. Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metab Disord 2021;:1-12. [PMID: 33821206 DOI: 10.1007/s40200-021-00779-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
237 Liu Y, Lu R, Wang J, Cheng Q, Zhang R, Zhang S, Le Y, Wang H, Xiao W, Gao H, Zeng L, Hong T. Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19. BMC Endocr Disord 2021;21:56. [PMID: 33771154 DOI: 10.1186/s12902-021-00717-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
238 Gazzaz ZJ. Diabetes and COVID-19. Open Life Sci 2021;16:297-302. [PMID: 33817321 DOI: 10.1515/biol-2021-0034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
239 Molteni E, Astley CM, Ma W, Sudre CH, Magee LA, Murray B, Fall T, Gomez MF, Tsereteli N, Franks PW, Brownstein JS, Davies R, Wolf J, Spector TD, Ourselin S, Steves CJ, Chan AT, Modat M. Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts. Sci Rep 2021;11:6928. [PMID: 33767292 DOI: 10.1038/s41598-021-86452-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
240 Sonmez A, Demirci I, Haymana C, Tasci I, Dagdelen S, Salman S, Ata N, Sahin I, Emral R, Cakal E, Atmaca A, Sahin M, Celik O, Demir T, Ertugrul D, Unluturk U, Caglayan M, Satman I. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia). J Diabetes 2021;13:585-95. [PMID: 33655669 DOI: 10.1111/1753-0407.13171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
241 Gamsızkan Z, Sungur MA, Erdemir G. How do older age, gender and risk groups affect protective behaviours and mental health in the COVID-19 pandemic? Int J Clin Pract 2021;75:e14150. [PMID: 33720469 DOI: 10.1111/ijcp.14150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
242 Zhang W, Li C, Xu Y, He B, Hu M, Cao G, Li L, Wu S, Wang X, Zhang C, Zhao J, Xie J, Xu Z, Li Q, Wang G. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019. Mediators Inflamm 2021;2021:8812304. [PMID: 33814982 DOI: 10.1155/2021/8812304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
243 Reay WR, El Shair SI, Geaghan MP, Riveros C, Holliday EG, McEvoy MA, Hancock S, Peel R, Scott RJ, Attia JR, Cairns MJ. Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function. Elife 2021;10:e63115. [PMID: 33720009 DOI: 10.7554/eLife.63115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
244 Samuel SM, Varghese E, Büsselberg D. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role. Trends Microbiol 2021:S0966-842X(21)00063-9. [PMID: 33785249 DOI: 10.1016/j.tim.2021.03.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 13.5] [Reference Citation Analysis]
245 Mekonnen CK, Ferede YM, Abate HK. Determinants of Dietary Adherence Among Type 2 Diabetes Patients Aimed COVID-19 at the University of Gondar Comprehensive Specialized Hospital. Diabetes Metab Syndr Obes 2021;14:917-27. [PMID: 33688226 DOI: 10.2147/DMSO.S297582] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
246 Baptista MC, Burton WN, Pawlecki B, Pransky G. A Physician's Guide for Workers' Return to Work During COVID-19 Pandemic. J Occup Environ Med 2021;63:199-220. [PMID: 33350662 DOI: 10.1097/JOM.0000000000002118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
247 Dhar SK, Sachdeva K, Das M. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis. Diabetes Metab Syndr 2021;15:639-41. [PMID: 33676871 DOI: 10.1016/j.dsx.2021.02.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
248 Berlie HD, Kale-Pradhan PB, Orzechowski T, Jaber LA. Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review. Ann Pharmacother 2021;55:1386-96. [PMID: 33657863 DOI: 10.1177/1060028021999473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
249 Granger C, Guedeney P, Arnaud C, Guendouz S, Cimadevilla C, Kerneis M, Kerneis C, Zeitouni M, Verdonk C, Legeai C, Lebreton G, Leprince P, Désiré E, Sorrentino S, Silvain J, Montalescot G, Hazan F, Varnous S, Dorent R. Clinical manifestations and outcomes of coronavirus disease-19 in heart transplant recipients: a multicentre case series with a systematic review and meta-analysis. Transpl Int 2021;34:721-31. [PMID: 33539616 DOI: 10.1111/tri.13837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
250 Chacko SR, DeJoy R 3rd, Lo KB, Albano J, Peterson E, Bhargav R, Gu F, Salacup G, Pelayo J, Azmaiparashvili Z, Rangaswami J, Patarroyo-Aponte G, Benzaquen S, Gupta E. Association of Pre-Admission Statin Use With Reduced In-Hospital Mortality in COVID-19. Am J Med Sci 2021;361:725-30. [PMID: 33667433 DOI: 10.1016/j.amjms.2021.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
251 Mirjalili H, Dastgheib SA, Shaker SH, Bahrami R, Mazaheri M, Sadr-Bafghi SMH, Sadeghizadeh-Yazdi J, Neamatzadeh H. Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis. J Diabetes Metab Disord 2021;:1-13. [PMID: 33654683 DOI: 10.1007/s40200-021-00768-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
252 Wurth R, Hajdenberg M, Barrera FJ, Shekhar S, Copacino CE, Moreno-Peña PJ, Gharib OAM, Porter F, Hiremath S, Hall JE, Schiffrin EL, Eisenhofer G, Bornstein SR, Brito JP, González-González JG, Stratakis CA, Rodríguez-Gutiérrez R, Hannah-Shmouni F. Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results? Postgrad Med J 2021:postgradmedj-2020-139392. [PMID: 33637639 DOI: 10.1136/postgradmedj-2020-139392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
253 Sloan M, Gordon C, Harwood R, Lever E, Wincup C, Bosley M, Brimicombe J, Pilling M, Sutton S, Holloway L, D'Cruz D. The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study. Rheumatol Adv Pract 2021;5:rkaa072. [PMID: 33604501 DOI: 10.1093/rap/rkaa072] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
254 Jain SK, Micinski D, Parsanathan R. l-Cysteine Stimulates the Effect of Vitamin D on Inhibition of Oxidative Stress, IL-8, and MCP-1 Secretion in High Glucose Treated Monocytes. J Am Coll Nutr 2021;40:327-32. [PMID: 33596158 DOI: 10.1080/07315724.2020.1850371] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
255 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
256 Moreb NA, Albandary A, Jaiswal S, Jaiswal AK. Fruits and Vegetables in the Management of Underlying Conditions for COVID-19 High-Risk Groups. Foods 2021;10:389. [PMID: 33578926 DOI: 10.3390/foods10020389] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
257 Nassar M, Nso N, Baraka B, Alfishawy M, Mohamed M, Nyabera A, Sachmechi I. The association between COVID-19 and type 1 diabetes mellitus: A systematic review. Diabetes Metab Syndr 2021;15:447-54. [PMID: 33592371 DOI: 10.1016/j.dsx.2021.02.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
258 Kenerly MJ, Shah P, Patel H, Racine R, Jani Y, Owens C, George V, Linder D, Owens J, Hess DC. Altered mental status is an independent predictor of mortality in hospitalized COVID-19 patients. Ir J Med Sci 2021. [PMID: 33566314 DOI: 10.1007/s11845-021-02515-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
259 Roberts J, Pritchard AL, Treweeke AT, Rossi AG, Brace N, Cahill P, MacRury SM, Wei J, Megson IL. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. Front Cardiovasc Med 2020;7:629933. [PMID: 33614744 DOI: 10.3389/fcvm.2020.629933] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 11.5] [Reference Citation Analysis]
260 Ergun-Longmire B, Clemente E, Vining-Maravolo P, Roberts C, Buth K, Greydanus DE. Diabetes education in pediatrics: How to survive diabetes. Dis Mon 2021;67:101153. [PMID: 33541707 DOI: 10.1016/j.disamonth.2021.101153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
261 Kasaliwal R, Jain S, Gupta N, Mathur N, Jain A, Rijhwani P. IMPACT OF DIABETES ON OUTCOME OF HOSPITALISED PATIENTS WITH COVID -19 PNEUMONIA: SINGLE CENTRE EXPERIENCE FROM NORTH INDIA. ijsr 2021. [DOI: 10.36106/ijsr/5301421] [Reference Citation Analysis]
262 Levitsky LL, Koren D. Editorial: Growth and development in a time of coronavirus. Curr Opin Endocrinol Diabetes Obes 2021;28:43-5. [PMID: 33229927 DOI: 10.1097/MED.0000000000000593] [Reference Citation Analysis]
263 Cervantes J, Sureen A, Galura G, Dodoo C, Dwivedi AK, Bashashati M, Zuckerman M, Meza A. Factors associated with COVID-19 severity and mortality among Hispanic patients living on the USA-Mexico border. J Investig Med 2021:jim-2020-001667. [PMID: 33514615 DOI: 10.1136/jim-2020-001667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
264 Malik SUF, Chowdhury PA, Hakim A, Islam MS, Alam MJ, Azad AK. Blood biochemical parameters for assessment of COVID-19 in diabetic and non-diabetic subjects: a cross-sectional study. Int J Environ Health Res 2021;:1-14. [PMID: 33504213 DOI: 10.1080/09603123.2021.1879741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
265 Magallón-botaya R, Oliván-blázquez B, Ramirez-cervantes KL, Mendez-lopez de la Mazanara F, Casajuana-closas M, Esteban-andrés E. ARE GEOGRAPHIC FACTORS ASSOCIATED WITH POORER OUTCOMES IN PATIENTS DIAGNOSED WITH COVID-19?. [DOI: 10.1101/2021.01.25.21250404] [Reference Citation Analysis]
266 Madsen KP, Willaing I, Rod NH, Varga TV, Joensen LE. Psychosocial health in people with diabetes during the first three months of the COVID-19 pandemic in Denmark. J Diabetes Complications 2021;35:107858. [PMID: 33573890 DOI: 10.1016/j.jdiacomp.2021.107858] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
267 Kandil H, Ibrahim AE, Afifi N, Arafa A. Diabetes and Risk of COVID-19 Mortality: A Systematic Review and Meta-Analysis. Infect Dis Clin Pract (Baltim Md) 2021;29:e195-7. [PMID: 34191909 DOI: 10.1097/IPC.0000000000000992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
268 Grabowski D, Overgaard M, Meldgaard J, Johansen LB, Willaing I. Disrupted Self-Management and Adaption to New Diabetes Routines: A Qualitative Study of How People with Diabetes Managed Their Illness during the COVID-19 Lockdown. Diabetology 2021;2:1-15. [DOI: 10.3390/diabetology2010001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
269 Martos-Benítez FD, Soler-Morejón CD, García-Del Barco D. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico. Intern Emerg Med 2021;16:1507-17. [PMID: 33411264 DOI: 10.1007/s11739-020-02597-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
270 Ahmed S, Gasparyan AY, Zimba O. Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 2021;41:243-56. [PMID: 33388969 DOI: 10.1007/s00296-020-04764-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 18.5] [Reference Citation Analysis]
271 Shrivastava S, Shrivastava P. Insights into the relationship between COVID-19 and diabetes mellitus: Public health perspective. J Med Soc 2021;35:48. [DOI: 10.4103/jms.jms_2_21] [Reference Citation Analysis]
272 Naebulharam A, Mujalled M, Alamir H, Ahmad A, Fayraq A, Alzahrani S. A review of the association between coronavirus disease 2019 and diabetes mellitus. IJMDC 2021. [DOI: 10.24911/ijmdc.51-1609265183] [Reference Citation Analysis]
273 Fox T, Ruddiman K, Lo KB, Peterson E, DeJoy R 3rd, Salacup G, Pelayo J, Bhargav R, Gul F, Albano J, Azmaiparashvili Z, Anastasopoulou C, Patarroyo-Aponte G. The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis. Acta Diabetol 2021;58:33-8. [PMID: 32804317 DOI: 10.1007/s00592-020-01592-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
274 Nawata K. Estimation of Diabetes Prevalence, and Evaluation of Factors Affecting Blood Glucose Levels and Use of Medications in Japan. Health 2021;13:1431-1451. [DOI: 10.4236/health.2021.1312102] [Reference Citation Analysis]
275 Abe T, Egbuche O, Igwe J, Jegede O, Wagle B, Olanipekun T, Onwuanyi A. Cardiovascular complications in COVID-19 patients with or without diabetes mellitus. Endocrinol Diabetes Metab. 2020;e00218. [PMID: 33614986 DOI: 10.1002/edm2.218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
276 Bain SC, Czernichow S, Bøgelund M, Madsen ME, Yssing C, McMillan AC, Hvid C, Hettiarachchige N, Panton UH. Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model. Curr Med Res Opin 2021;37:27-36. [PMID: 33306421 DOI: 10.1080/03007995.2020.1862775] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
277 Kamioka H, Mori Y, Horiuchi T, Hayashi T, Ohmura K, Yamaguchi S, Kato M. Association of Daily Home-Based Hot Water Bathing and Glycemic Control in Ambulatory Japanese Patients with Type 2 Diabetes Mellitus During the COVID-19 Pandemic: A Multicenter Cross-Sectional Study. Diabetes Metab Syndr Obes 2020;13:5059-69. [PMID: 33376375 DOI: 10.2147/DMSO.S279270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
278 Saand AR, Flores M, Kewan T, Alqaisi S, Alwakeel M, Griffiths L, Wang X, Han X, Burton R, Al-Jaghbeer MJ, Abi Fadel F. Does inpatient hyperglycemia predict a worse outcome in COVID-19 intensive care unit patients? J Diabetes 2021;13:253-60. [PMID: 33216443 DOI: 10.1111/1753-0407.13137] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
279 Damiano S, Sozio C, La Rosa G, Santillo M. NOX-Dependent Signaling Dysregulation in Severe COVID-19: Clues to Effective Treatments. Front Cell Infect Microbiol 2020;10:608435. [PMID: 33384971 DOI: 10.3389/fcimb.2020.608435] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
280 Lee SC, Son KJ, Han CH, Jung JY, Park SC. Impact of comorbid asthma on severity of coronavirus disease (COVID-19). Sci Rep 2020;10:21805. [PMID: 33311519 DOI: 10.1038/s41598-020-77791-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 15.0] [Reference Citation Analysis]
281 Jiang N, Chen Z, Liu L, Yin X, Yang H, Tan X, Wang J, Li H, Tian M, Lu Z, Xiong N, Gong Y. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study. Diabetes Res Clin Pract 2021;173:108619. [PMID: 33310173 DOI: 10.1016/j.diabres.2020.108619] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
282 Giorgino F, Bhana S, Czupryniak L, Dagdelen S, Galstyan GR, Janež A, Lalić N, Nouri N, Rahelić D, Stoian AP, Raz I. Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa. Diabetes Res Clin Pract 2021;172:108617. [PMID: 33310175 DOI: 10.1016/j.diabres.2020.108617] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
283 Riahi S, Sombra LRS, Lo KB, Chacko SR, Neto AGM, Azmaiparashvili Z, Patarroyo-Aponte G, Rangaswami J, Anastasopoulou C. Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19. Endocr Res 2021;46:45-50. [PMID: 33275067 DOI: 10.1080/07435800.2020.1856865] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
284 Gupta SK, Lakshmi PVM, Kaur M, Rastogi A. Role of self-care in COVID-19 pandemic for people living with comorbidities of diabetes and hypertension. J Family Med Prim Care 2020;9:5495-501. [PMID: 33532385 DOI: 10.4103/jfmpc.jfmpc_1684_20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
285 Alkundi A, Momoh R. COVID-19 infection and diabetes mellitus. JDMDC 2020;7:119-120. [DOI: 10.15406/jdmdc.2020.07.00212] [Reference Citation Analysis]
286 Pathangey G, Fadadu PP, Hospodar AR, Abbas AE. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies. Am J Physiol Lung Cell Mol Physiol 2021;320:L301-30. [PMID: 33237815 DOI: 10.1152/ajplung.00259.2020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
287 Liang X, Xu J, Xiao W, Shi L, Yang H. The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates. Hormones (Athens) 2021;20:409-14. [PMID: 33236191 DOI: 10.1007/s42000-020-00259-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
288 Segal JP, Mak JWY, Mullish BH, Alexander JL, Ng SC, Marchesi JR. The gut microbiome: an under-recognised contributor to the COVID-19 pandemic? Therap Adv Gastroenterol 2020;13:1756284820974914. [PMID: 33281941 DOI: 10.1177/1756284820974914] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 10.7] [Reference Citation Analysis]
289 Wee AKH. COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice? Med Hypotheses 2021;146:110374. [PMID: 33257090 DOI: 10.1016/j.mehy.2020.110374] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
290 Neumann-Podczaska A, Chojnicki M, Karbowski LM, Al-Saad SR, Hashmi AA, Chudek J, Tobis S, Kropinska S, Mozer-Lisewska I, Suwalska A, Tykarski A, Wieczorowska-Tobis K. Clinical Characteristics and Survival Analysis in a Small Sample of Older COVID-19 Patients with Defined 60-Day Outcome. Int J Environ Res Public Health 2020;17:E8362. [PMID: 33198124 DOI: 10.3390/ijerph17228362] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
291 Carrasco-Sánchez FJ, López-Carmona MD, Martínez-Marcos FJ, Pérez-Belmonte LM, Hidalgo-Jiménez A, Buonaiuto V, Suárez Fernández C, Freire Castro SJ, Luordo D, Pesqueira Fontan PM, Blázquez Encinar JC, Magallanes Gamboa JO, de la Peña Fernández A, Torres Peña JD, Fernández Solà J, Napal Lecumberri JJ, Amorós Martínez F, Guisado Espartero ME, Jorge Ripper C, Gómez Méndez R, Vicente López N, Román Bernal B, Rojano Rivero MG, Ramos Rincón JM, Gómez Huelgas R; SEMI-COVID-19 Network. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann Med 2021;53:103-16. [PMID: 33063540 DOI: 10.1080/07853890.2020.1836566] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 21.3] [Reference Citation Analysis]
292 Aung N, Khanji MY, Munroe PB, Petersen SE. Causal Inference for Genetic Obesity, Cardiometabolic Profile and COVID-19 Susceptibility: A Mendelian Randomization Study. Front Genet 2020;11:586308. [PMID: 33262790 DOI: 10.3389/fgene.2020.586308] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
293 Formiga F, Tarazona-santabalbina FJ. Diabetes y COVID-19 en el adulto mayor, simbiosis nociva. Revista Española de Geriatría y Gerontología 2020;55:315-316. [DOI: 10.1016/j.regg.2020.07.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
294 Pugliese G, Vitale M, Resi V, Orsi E. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)? Acta Diabetol 2020;57:1275-85. [PMID: 32865671 DOI: 10.1007/s00592-020-01586-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
295 Cerullo G, Negro M, Parimbelli M, Pecoraro M, Perna S, Liguori G, Rondanelli M, Cena H, D'Antona G. The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19. Front Immunol 2020;11:574029. [PMID: 33193359 DOI: 10.3389/fimmu.2020.574029] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 19.0] [Reference Citation Analysis]
296 Galanis P, Andreadaki E, Kleanthous E, Georgiadou A, Evangelou E, Kallergis G, Kaitelidou D. Determinants of psychological distress during the COVID-19 pandemic and the lockdown measures: a nationwide on-line survey in Greece and Cyprus.. [DOI: 10.1101/2020.10.25.20219006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
297 Zhou J, Liu C, Sun Y, Huang W, Ye K. Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study. Brain Behav Immun 2021;91:383-92. [PMID: 33148439 DOI: 10.1016/j.bbi.2020.10.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
298 Zhang B, Dong C, Li S, Song X, Wei W, Liu L. Triglyceride to High-Density Lipoprotein Cholesterol Ratio is an Important Determinant of Cardiovascular Risk and Poor Prognosis in Coronavirus Disease-19: A Retrospective Case Series Study. Diabetes Metab Syndr Obes 2020;13:3925-36. [PMID: 33122929 DOI: 10.2147/DMSO.S268992] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
299 Wu S, Xue L, Legido-Quigley H, Khan M, Wu H, Peng X, Li X, Li P. Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital. PLoS One 2020;15:e0240959. [PMID: 33085709 DOI: 10.1371/journal.pone.0240959] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
300 Mehraeen E, Karimi A, Barzegary A, Vahedi F, Afsahi AM, Dadras O, Moradmand-Badie B, Seyed Alinaghi SA, Jahanfar S. Predictors of mortality in patients with COVID-19-a systematic review. Eur J Integr Med. 2020;40:101226. [PMID: 33101547 DOI: 10.1016/j.eujim.2020.101226] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 28.0] [Reference Citation Analysis]
301 Sadhu AR, Serrano IA, Xu J, Nisar T, Lucier J, Pandya AR, Patham B. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study. J Diabetes Sci Technol 2020;14:1065-73. [PMID: 33063556 DOI: 10.1177/1932296820964264] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
302 Du M, Lin YX, Yan WX, Tao LY, Liu M, Liu J. Prevalence and impact of diabetes in patients with COVID-19 in China. World J Diabetes 2020; 11(10): 468-480 [PMID: 33133394 DOI: 10.4239/wjd.v11.i10.468] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
303 Molteni E, Astley CM, Ma W, Sudre CH, Magee LA, Murray B, Fall T, Gomez MF, Tsereteli N, Franks PW, Brownstein JS, Davies R, Wolf J, Spector TD, Ourselin S, Steves CJ, Chan AT, Modat M. SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology. medRxiv 2020:2020. [PMID: 32839787 DOI: 10.1101/2020.08.17.20161760] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
304 Shivane VK, Lila AR, Bandgar TR. Type 2 diabetic Asian Indians and COVID-19: Lessons learnt so far from the ongoing pandemic. J Postgrad Med 2020;66:179-81. [PMID: 33037170 DOI: 10.4103/jpgm.JPGM_602_20] [Reference Citation Analysis]
305 Olickal JJ, Chinnakali P, Suryanarayana BS, Ulaganeethi R, Kumar SS, Saya GK. Effect of COVID19 pandemic and national lockdown on persons with diabetes from rural areas availing care in a tertiary care center, southern India. Diabetes Metab Syndr 2020;14:1967-72. [PMID: 33059300 DOI: 10.1016/j.dsx.2020.10.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
306 Almaghlouth NK, Davis MG, Davis MA, Anyiam FE, Guevara R, Antony SJ. Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study. J Med Virol 2021;93:2021-8. [PMID: 32986248 DOI: 10.1002/jmv.26560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
307 Liu Y, Xie H, Gao H, Xie C. Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22592. [PMID: 33031311 DOI: 10.1097/MD.0000000000022592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
308 Kirwan R, McCullough D, Butler T, Perez de Heredia F, Davies IG, Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience 2020;42:1547-78. [PMID: 33001410 DOI: 10.1007/s11357-020-00272-3] [Cited by in Crossref: 113] [Cited by in F6Publishing: 131] [Article Influence: 37.7] [Reference Citation Analysis]
309 Liu Y, Yang Y, Chen Y, Zhou L, Xiong Q, Xie C. The relationship between hyperglycemia and the infection of COVID-19 in diabetic patients: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21806. [PMID: 32899010 DOI: 10.1097/MD.0000000000021806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
310 Choi GJ, Kim HM, Kang H. The Potential Role of Dyslipidemia in COVID-19 Severity: an Umbrella Review of Systematic Reviews. J Lipid Atheroscler 2020;9:435-48. [PMID: 33024735 DOI: 10.12997/jla.2020.9.3.435] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
311 Holly JMP, Biernacka K, Maskell N, Perks CM. Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle. Front Endocrinol (Lausanne) 2020;11:582870. [PMID: 33042029 DOI: 10.3389/fendo.2020.582870] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
312 Kruglikov IL, Shah M, Scherer PE. Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions. Elife 2020;9:e61330. [PMID: 32930095 DOI: 10.7554/eLife.61330] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 15.0] [Reference Citation Analysis]
313 Acharya D, Lee K, Lee DS, Lee YS, Moon SS. Mortality Rate and Predictors of Mortality in Hospitalized COVID-19 Patients with Diabetes. Healthcare (Basel) 2020;8:E338. [PMID: 32933191 DOI: 10.3390/healthcare8030338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
314 Barbu MG, Thompson RJ, Thompson DC, Cretoiu D, Suciu N. The Impact of SARS-CoV-2 on the Most Common Comorbidities-A Retrospective Study on 814 COVID-19 Deaths in Romania. Front Med (Lausanne) 2020;7:567199. [PMID: 33015111 DOI: 10.3389/fmed.2020.567199] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
315 Ufuk F, Demirci M, Sagtas E, Akbudak IH, Ugurlu E, Sari T. The prognostic value of pneumonia severity score and pectoralis muscle Area on chest CT in adult COVID-19 patients. Eur J Radiol 2020;131:109271. [PMID: 32942198 DOI: 10.1016/j.ejrad.2020.109271] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
316 Kumar Singh A, Singh R. Letter to the editor in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)". Diabetes Metab Syndr 2020;14:937-8. [PMID: 32593934 DOI: 10.1016/j.dsx.2020.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
317 Gangopadhyay KK. "Does having diabetes increase chances of contracting COVID-19 infection?". Diabetes Metab Syndr 2020;14:765-6. [PMID: 32512520 DOI: 10.1016/j.dsx.2020.05.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
318 Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.). Diabetes Metab Syndr 2020;14:1147-8. [PMID: 32668400 DOI: 10.1016/j.dsx.2020.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
319 Grabowski D, Meldgaard J, Hulvej Rod M. Altered Self-Observations, Unclear Risk Perceptions and Changes in Relational Everyday Life: A Qualitative Study of Psychosocial Life with Diabetes during the COVID-19 Lockdown. Societies 2020;10:63. [DOI: 10.3390/soc10030063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
320 de Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M, Bertoluci MC; Brazilian Diabetes Society Study Group (SBD). Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr 2020;12:75. [PMID: 32874207 DOI: 10.1186/s13098-020-00586-4] [Cited by in Crossref: 117] [Cited by in F6Publishing: 131] [Article Influence: 39.0] [Reference Citation Analysis]
321 Kutlutürk F. COVID-19 Pandemisi ve Diabetes Mellitus. Turkish Journal of Diabetes and Obesity 2020;4:130-7. [DOI: 10.25048/tudod.746139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
322 Goel M, Gonzalez V, Badran R, Tegeltija V. Clinical Course of COVID-19 in Identical Twins. J Med Cases 2020;11:299-302. [PMID: 33984085 DOI: 10.14740/jmc3536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
323 Katsiki N, Ferrannini E. Anti-inflammatory properties of antidiabetic drugs: A "promised land" in the COVID-19 era? J Diabetes Complications 2020;34:107723. [PMID: 32900588 DOI: 10.1016/j.jdiacomp.2020.107723] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
324 Odeh R, Gharaibeh L, Daher A, Kussad S, Alassaf A. Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents' perspectives on the use of telemedicine. Diabetes Res Clin Pract 2020;168:108393. [PMID: 32858098 DOI: 10.1016/j.diabres.2020.108393] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
325 Meza JL, Triana A, De Avila I, Del Rio-pertuz G, Viasus D. Diabetic Ketoacidosis Precipitated by COVID-19 in Patients Without Respiratory Symptoms: Case Reports. Cureus 2020. [DOI: 10.7759/cureus.10031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
326 Fillmore NR, La J, Szalat RE, Tuck DP, Nguyen V, Yildirim C, Do NV, Brophy MT, Munshi NC. Prevalence and outcome of Covid-19 infection in cancer patients: a national VA study.. [DOI: 10.1101/2020.08.21.20177923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
327 Kim MK, Jeon JH, Kim SW, Moon JS, Cho NH, Han E, You JH, Lee JY, Hyun M, Park JS, Kwon YS, Choi YK, Kwon KT, Lee SY, Jeon EJ, Kim JW, Hong HL, Kwon HH, Jung CY, Lee YY, Ha E, Chung SM, Hur J, Ahn JH, Kim NY, Kim SW, Chang HH, Lee YH, Lee J, Park KG, Kim HA, Lee JH. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea. Diabetes Metab J 2020;44:602-13. [PMID: 32794386 DOI: 10.4093/dmj.2020.0146] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 21.7] [Reference Citation Analysis]
328 Mishra PK, Tandon R, Byrareddy SN. Diabetes and COVID-19 risk: an miRNA perspective. Am J Physiol Heart Circ Physiol 2020;319:H604-9. [PMID: 32762561 DOI: 10.1152/ajpheart.00489.2020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
329 Harmouch F, Shah K, Hippen JT, Kumar A, Goel H. Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID-19 patients. J Med Virol 2021;93:973-82. [PMID: 32710646 DOI: 10.1002/jmv.26347] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
330 Scheen AJ. Metformin and COVID-19: From cellular mechanisms to reduced mortality. Diabetes Metab 2020;46:423-6. [PMID: 32750451 DOI: 10.1016/j.diabet.2020.07.006] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 28.7] [Reference Citation Analysis]
331 Vas P, Hopkins D, Feher M, Rubino F, B Whyte M. Diabetes, obesity and COVID-19: A complex interplay. Diabetes Obes Metab 2020;22:1892-6. [PMID: 32627299 DOI: 10.1111/dom.14134] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
332 Guo L, Shi Z, Zhang Y, Wang C, Do Vale Moreira NC, Zuo H, Hussain A. Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis. Diabetes Res Clin Pract 2020;166:108346. [PMID: 32710998 DOI: 10.1016/j.diabres.2020.108346] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
333 Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782-792. [PMID: 32687793 DOI: 10.1016/s2213-8587(20)30238-2] [Cited by in Crossref: 478] [Cited by in F6Publishing: 518] [Article Influence: 159.3] [Reference Citation Analysis]
334 Li G, Deng Q, Feng J, Li F, Xiong N, He Q. Clinical Characteristics of Diabetic Patients with COVID-19. J Diabetes Res 2020;2020:1652403. [PMID: 32851093 DOI: 10.1155/2020/1652403] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
335 Samimagham HR, Arabi M, Hooshyar D, Kazemijahromi M. The Association of Non-Steroidal Anti-Inflammatory Drugs with COVID-19 Severity and Mortality. Arch Clin Infect Dis 2020;15. [DOI: 10.5812/archcid.106847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
336 Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, Wooster L, Rotter JI, Guo X, Malhotra R. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol 2020;92:1875-83. [PMID: 32441789 DOI: 10.1002/jmv.26050] [Cited by in Crossref: 310] [Cited by in F6Publishing: 339] [Article Influence: 103.3] [Reference Citation Analysis]
337 Lagunas-rangel FA, Chávez-valencia V. Laboratory findings that predict a poor prognosis in COVID-19 patients with diabetes: A meta-analysis.. [DOI: 10.1101/2020.07.02.20145391] [Reference Citation Analysis]
338 Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, Qi X, Cua IH, Suh JI, Park JG, Putcharoen O, Kaewdech A, Piratvisuth T, Treeprasertsuk S, Park S, Wejnaruemarn S, Payawal DA, Baatarkhuu O, Ahn SH, Yeo CD, Alonzo UR, Chinbayar T, Loho IM, Yokosuka O, Jafri W, Tan S, Soo LI, Tanwandee T, Gani R, Anand L, Esmail ES, Khalaf M, Alam S, Lin CY, Chuang WL, Soin AS, Garg HK, Kalista K, Batsukh B, Purnomo HD, Dara VP, Rathi P, Al Mahtab M, Shukla A, Sharma MK, Omata M;  APASL COVID Task Force; APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640). Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020;14:690-700. [PMID: 32623632 DOI: 10.1007/s12072-020-10072-8] [Cited by in Crossref: 144] [Cited by in F6Publishing: 156] [Article Influence: 48.0] [Reference Citation Analysis]
339 Johnson BS, Laloraya M. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization. Cytokine Growth Factor Rev 2020;54:32-42. [PMID: 32747157 DOI: 10.1016/j.cytogfr.2020.06.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 10.7] [Reference Citation Analysis]
340 Reay WR, Shair SIE, Geaghan MP, Riveros C, Holliday EG, Mcevoy MA, Hancock S, Peel R, Scott RJ, Attia JR, Cairns MJ. Genetically informed precision drug repurposing for lung function and implications for respiratory infection.. [DOI: 10.1101/2020.06.25.20139816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
341 Singh AK, Khunti K. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Res Clin Pract 2020;165:108266. [PMID: 32533989 DOI: 10.1016/j.diabres.2020.108266] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
342 Nimeri AA, Matthews BD. Reentry to Metabolic and Bariatric Surgery During the COVID19 Pandemic. Obes Surg 2020;30:4652-3. [PMID: 32472359 DOI: 10.1007/s11695-020-04736-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
343 Dalan R. Metformin, neutrophils and COVID-19 infection. Diabetes Res Clin Pract 2020;164:108230. [PMID: 32446796 DOI: 10.1016/j.diabres.2020.108230] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
344 Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients. 2020;12. [PMID: 32438620 DOI: 10.3390/nu12051466] [Cited by in Crossref: 257] [Cited by in F6Publishing: 275] [Article Influence: 85.7] [Reference Citation Analysis]
345 Rizun V, Havrylets Y, Petrenko-lysak A, Tukaiev S, Popov A, Ivaskevych D, Yachnik Y. Stressogenic Elements of the Latent Impact of Real Media Reports on the COVID-19 Pandemic on Social Groups (Reporting the Methodology and Research Planning). Aktual pitannâ masovoï komun 2020. [DOI: 10.17721/2312-5160.2020.28.10-27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
346 Mondaini N. Phosphodiesterase Type 5 Inhibitors and COVID-19: Are They Useful In Disease Management? World J Mens Health 2020;38:254-5. [PMID: 32573126 DOI: 10.5534/wjmh.200089] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
347 [DOI: 10.1101/2020.11.09.20223792] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Reference Citation Analysis]